Prof.Dr. Marıa Del Pılar Laguna PES | Trouver un Docteur

Lieu de naissance

BARSELONA İSPANYA

Langues étrangères

İNGİLİZCE,İSPANYOLCA

Envoyer un e-mail

Expérience

2018Istanbul Medipol University, Istanbul, Turkey

2000 - 2002UMC St. Radboud Nijmegen

1995 - 2000Hospital Gral La Mancha Centro, Alcazar de San Juan

1989 - 1995Fundación Puigvert Barcelona

1989 - 1995Autonomous Üniversitesi Barcelona

1982 - 1988Hospital del Sagrado Corazón Barcelona

2015Akademik Tıp Merkezi, Amsterdam

2002Akademik Tıp Merkezi Amsterdam

Formation

1982Hospital del Sagrado Corazón Barcelona, Üroloji Bölümü

1979Autonomous Üniversitesi, Barselona, Tıp Bölümü

Publications

1981:

J. Sacristan Sanfelipe, M.P. Laguna Pes, J.L. Batalla Cadira. Orquidopexia. Arch Esp Urol 2; 34(2): 133-142, 1981.

1988:

M.P. Laguna Pes, P.J. Martorell Llort, J. Sacristan Sanfelipe, J.L. Batalla Cadira. Pseudoquiste suprarrenal . A propósito de un caso. Actas Urol Esp; 12(5): 464-468, 1988.

1989:

J.L. Batalla Cadira, M.P. Laguna Pes. Le Meat apical dans le traitement chirurgical de l´hipospadias. J Urol; 95(4): 235-237, 1989.

1990:

J. Vicente Rodriguez, J. Salvador Bayarri, M.P. Laguna Pes, F. Algaba, J. Caffaratti. Laserterapia de los tumores superficiales de vejiga. Arch Esp Urol; 43: Suppl 2, 1990.

F. Solé Balcells, J. Vincente Rodriguez, J. Paulo, M.P. Laguna Pes. Le traitement des tumeurs superficieues de la vessie. Pathol Biol; 38(8): 800-803, 1990.

1991:

J. Vicente Rodriguez, M.P. Laguna Pes, I. Diaz, F. Algaba, J. Calaf. Tratamiento de la Endometriosis vesical con ND-Yag Laser. Arch Esp Urol; 44(2): 169-171, 1991.

J. Vicente Rodriguez, J. Salvador Balyarri, M.P. Laguna Pes, F. Algaba. Histological Evaluation of Superficial Bladder Tumors Treated by Nd-YAG Laser and Transurethral Resection. Eur Urol; 20(3): 192-196, 1991.

J. Vicente Rodriguez, M.P. Laguna Pes, D. Duarte, F. Algaba, G. Chéchile. Carcinoma In Situ as a prognostic factor for G3pT1 bladder tumors. Br J Urol; 68: 380- 382, 1991.

1992:

LA. Farina, M.P. Laguna Pes, J. Palou Redorta, F. Algaba, J.M. Santaularia, J. Vicente Rodriguez. Adenoma nefrogénico en el curso del tratamiento con BCG intravesical. Arch Esp Urol; 45(2): 153-154, 1992.

J. Palou Redorta, J.E. Batista Miranda, M.P. Laguna Pes, J. Vicente Rodriguez. Fiebre farmacológica por isoniacida profilactica en instilaciones vesicales con BCG. Actas Urol Esp; 16(3): 257-258, 1992.

O. Laucirica, F. Izquierdo, J. Marti, M.P. Laguna Pes, P. Paulo Redorta, J. Vicente Rodriguez. Hemangiomas renales: caso clinico y revision bibliografica. Actas Urol Esp; 16(4): 366-370, 1992.

H. Villavicencio Marvrich, EA. Granados, P. Paulo Redorta, M.P. Laguna Pes. Carcinoma renal bilateral. Actas Urol Esp; 16(5): 389-393, 1992.

J. Palou Redorta, M.P. Laguna Pes. Bacilo de Calmette –Guerin Intravesical. Med Clin (Barc); 98(16): 622-623, 1992.

H. Villavecencio, M.P.Laguna Pes, J. Caparros, E. Begalado. Sustitución vesical con ileon destubularizado tipo Studer. Urologia Panamericana; 4: 15-20, 1992.

1993:

L.A. Farina, J.M. Iglesias, C. Villanueva, J. Salvador Bayarri, M.P. Laguna Pes, H. Villavicencio Marvrich. Pseudo obstrucción colónica aguda (Sindrome de Ogilvie) tras Nefrectomia por Carcinoma renal: persistencia después de la colonoscopia descompresiva y resolución espontanea. Actas Urol Esp; 17(2): 135-138, 1993.

H. Villavicencio Marvrich, M.P. Laguna Pes, J. Salvador Bayarri, F.J. Solé Balcells. Gastrocistoplastia en el adulto por Insuficiencia Renal. Actas Urol Esp; 17(2): 148- 152, 1993.

J. Vicente Rodriguez, J. Salvador Bayarri, M.P. Laguna Pes. Les proteses intraprostatiques. J Urol (Paris); 99(6):324-327, 1993.

R.O. Parra, M.P. Laguna Pes, M. Garcia Perez, S. Isorna de la Riva. La prostatectomia radical perineal en la era de la laparoscopia. Arch Esp de Urol; 46(10): 879-886, 1993.

1994:

O. Wuhl, R. Vila, P. Barcelo, M.P. Laguna Pes, A. Roussaud. Litiasis de 2,8 Dihydroxiadenina: comunicación de 3 casos. Actas Urol Esp; 18(1):43-46, 1994.

J. Vicente Rodriguez, M.P. Laguna Pes, J. Salvador Bayarri, F. Algaba, J.M. Santaularia Segura, H. Villavicencio Mavrich. La biopsia endoscópica en el estadiaje del tumor vesical infiltrante. Arch Esp de Urol; 47(1): 24-30, 1994.

M.P. Laguna Pes, E. Sanchotene, J. Martinez de Hurtado, J. Ponce de Leon, A. Rousaud, FJ. Solé Balcells. Des Onds de choc jusqu´a l´ureterolithotomie : quelques cas pratiques. Ann Urol Paris; 28(2): 93-101, 1994.

H. Villavicencio Marcrich, M.P. Laguna Pes, J. Ponce de Leon. Impacto clinico del tratamiento Neoadyuvante a prostatectomia radical en el cancer prostático localmente avanzado. Actas Urol Esp; 18 suppl: 404-408, 1994.

H. Villavicencio Marvrich and M.P. Laguna Pes. Use of the Stomach in Bladder Augmentation or Replacement. EBU, European Urology Update Series, 3, nº 19, 1994.

1995:

Vicente Rodroguez, F.J. Burgos and M.P. Laguna Pes. Behaviour, Indications and Complications of JJ Stents. J. EBU. European Urology Update Series, 4, nº 17, 1995.

J. Vicente Rodriguez, M.P. Laguna Pes, J. Palou Redorta, F.J. Solé Balcells. Transitional Cell Carcinoma in the Upper Urinary Tract: Diagnosis and Management Urology. Inter, 8-10, January, 1995.

C. Errando Smet, M.P. Laguna Pes, J. Salvador Bayarri, J.Vicente Rodriguez. Litotricia endoscópica mediante Lithoclast : nuestra experiencia. Arch Esp Urol; 48(6): 621-624, 1995.

M.P. Laguna Pes, A. Gimeno, C. Guinda Sevillano, J. Borrego Hernando, A. Zazo Romojaro, J. Vicente Rodriguez. Le Catheter double J dans le traitement par ondes de choc de la lithiase renale. Ann Urol; 29: 364-369, 1995.

C. Errando Smet, J. Huguet, R. Regalado, G. Chéchile, A. Rousaud, M.P. Laguna Pes, J. Vicente Rodriguez. Chirurgie a ciel ouvert de la lithiase du bassinet, resultats et complications das l´ere de la lithotripsie estra-corporellle. Ann Urol; 29: 378-381, 1995.

F. Monreal, M.P. Laguna Pes. Sepsis urinaria : patogenia y fisiopatologia. Act Fund Puigvert; 14: 159-162, 1995.

1996:

M.P. Laguna Pes, F. Algaba, J. Salvador Bayarri, M. Montlleó y J. Vicente Rodriguez. Tratamiento de la Hiperplasia Benigna de la Prostata (HBP) con Laser de control visual. Evaluación a dos años y hallazgos anatomopatologicos. Actas Urol Esp, Septiembre 1996.

M.P. Laguna Pes et R. Regalado. La formation des urologues en Europe : l´Espagne. URO Jonction; 23: 12-14, Diciembre 95/Enero 1996.

C. Errando Smet, M.P. Laguna Pes, J. Salvador Bayarri, J. Vicente Rodriguez. Cirugia endoscópica del diverticulo vesical. Actas Urol Esp; 20(9): 783-785, 1996.

J. Palou Redorta, J. Sanchez, M.P. Laguna Pes. Immunoterapia con BCG y verrugas vulgares. Actas Urol Esp; 20(10): 928-929, 1996. Carta.

F. Monreal, J. Caparros, M.P. Laguna Pes, A. Rosales, H. Villavicencio Marvirch. Riñon poliquistico del adulto y trasplante renal: nuestra experiencia. Arch Esp urol; 49(10): 1029-1033, 1996.

J. Palou Redorta, B. Xavier, M.P. Laguna Pes, M. Montlleó, J. Vicente Rodriguez. In Situ Transitional Cell Carcinoma Involvement of Prostatic Urethra: Bacille Calmette – Guerin Therapy without Previous Transurethral Resection of the Prostate. Urology, 47: 1-3, 1996.

1997:

J. Boullier, M.P. Laguna Pes, R. Parra. Treatment Options in DistaL Ureteral Stones. Arch Esp Urol, sección Internacional, 50, 2 (208-213), 1997.

J. Palou Redorta, MP. Laguna Pes, F. Algaba et al. Immunoterapia con BCG y verrugas vulgares. J Br J Urol; suppl. 80: 32, 1997.

C. Guinda Sevillano, M.P. Laguna Pes, J. Borrigo, A. Gimeno, A. Zazo Romojaro. Ecografia vesical externa . Aplicaciones. Urol Integr Invest; 1: 217-226, 1997.

1998:

M.P. Laguna Pes, J. Borrego Hernando, A. Gimeno Collado. Hiperplasis Benigna de la Prostata. Boletin de Información Farmacoterapeutica. Atención primaria de Ciudad Real. Insalud; vol 4: nº 1, 1998 .

J. Borrego Hernando, C. Guinda Sevillano, M.P. Laguna Pes, A. Zazo Romojaro, A. Gimeno Collado, R. Cuesta, A. Amigo Echenagusia. Tumor germinal retroperitoneal ¿ extragonadal o fenomeno de burned -out del primario testicular? Presentacion de un caso clinico. Actas Urol Esp; 22(2): 170-174, 1998.

A. Garcia, J. Borrego Hernando, A. Zazo Romojaro, A. Gimeno Collado, C. Guinda Sevillano, M.P. Laguna Pes. Lithotripsie vesicale par voie percutanée sus-pubienne. Ann Urol; vol 32(5): 308-311, 1998.

C. Guinda Sevillano, J. Borrego Hernando, M.P. Laguna Pes, A. Gimeno Collado, A. Zazo Romojaro, A. Amigo Echenagusia. Rabdomiosarcoma paratesticular. A propósito de un caso y revisión de la literatura. Actas Urol Esp; 22(8): 690-694, 1998.

M.P. Laguna Pes. Prólogo a la edición española de los AUA Update Series. (lecciones 21-30). 1998.

2000:

M.P. Laguna Pes and G. Alivizatos. PSA and Prostatic Benign Hyperplasia. Current Opinion in Urology; Vol 10, Nº 1, 2000.

J.M. Sanchez Merino, C. Guillan Maquieira, L. Parra Muntaner, S.C. Gomez Cisneros, M.P. Laguna Pes, J. Garcia Alonso. Abordaje transvesical de las fistulas vesicovaginales no comlicadas. Actas Urol Esp; 24(2): 189-185, 2000.

M.P. Laguna Pes, C. Guinda Sevillano, A. Zazo Romojaro, J. Dominguez, A. Garcia Luzon, J. Borrego Hernando, A. Gimeno Collado. Utilidad clinica de la ratio PSA libre/PSA total en el diagnostico precoz del cancer de prostata. Arch Esp Urol; 53 (4): 333-341, 2000.

M.P. Laguna Pes, R. Muchter, FMJ. Debruyne. Transurethral Microwave Thermotherapy. An Historical overview. J Endourol; 14: 603-609, 2000.

J.J.M.C.H. de la Rosette, M.P. Laguna Pes, G. Pace, B.B. Kortmann, O. Selvaggio, F.M.J. Debruyne. Efficacy and safety of the new high-energy 30-minute transurethral microwave thermotherapy: results of 1-year follow-up in a multicenter study. Tech Urol: 271-275, 2000.

2001:

M.P. Laguna Pes, J.J.M.C.H. de la Rosette. The endoscopic approach of the distal ureter in a nephroureterectomy for upper urinary tract tumor : a review. J Urol; 166(6): 2017-2022, 2001.

A critical evaluation of Transurethral Hot-Water Balloon Thermoablation: true facts and fiction. JJMCH. de la Rosette, G. Alivizatos, M.P. Laguna Pes. Current Urology Reports; 2: 302-305, 2001.

J. Palou, M.P. Laguna Pes , F. Millán-Rodriguez, R.R. Hall, J. Salvador bayarri, J. Vicente Rodriguez-Rodriguez. Control Group and maintenence treatment with Bacillus Calmette-Guerin for Carcinoma in Situ and / or High Grade Bladder Tumors. J Urol, 165: 1488-1491, 2001.

M.P. Laguna Pes, G. Pizzocaro, O. Klepp, F. Algaba, L. Kisbenedek, O. Leiva and the EAU Oncological Urology Working Group. EAU Guidelines on Testicular Cancer. Eur Urol; 40: 102-110, 2001.

2002:

J.J.M.C.H. de la Rosette, F.Smedts, C. Schoots, H. Hoek, M.P. Laguna Pes. Changing patterns of keratin expression characterize functional maturation in developing human bladder. J Urol; 168(2): 709-717, 2002.

J.J.M.C.H. de la Rosette, C.C. Abbou, J. Rassweiler, M.P. Laguna Pes, C.C. Schulman. Laparoscopic radical prostatectomy: a European virus with global potentials. Arch. Esp. Urol; 55(6): 603-609, 2002.

M.P. Laguna Pes. Cirugia laparoscopica? Debe hacerse todo lo que puede hacerse? O la prueba del tiempo. Editorial. Arch Urol Esp; 55(6): 591-593, 2002.

J. Veltman, T. Goossen, M.P. Laguna Pes, H. Wijkstra, J.J.M.C.H. de la Rosette. New technical improvements for TRUS in diagnosis of prostate cancer. Eur. Urol; 1(6): 8-14, 2002.

J. Vanderkerken, J.J.M.C.H. de la Rosette, M.P. Laguna Pes, F.M.J. Debruyne. How and when to take prostate biopsies. Eur. Urol; 1(6): 15-20, 2002.

M.P. Laguna Pes, L.A. Kiemeney, F.M.J. Debruyne, J.JM.C.H. de la Rosette. Baseline prostatic specific antigen does not predict the outcome of high energy transurethral microwave thermotherapy. J Urol; 167 :1727-1730, 2002.

M.P. Laguna Pes, M. Hatzinger, J. Rassweiler. Simulators and endourological training. Curr Opin Urol; 12: 209-215, 2002.

2003:

M.P. Laguna Pes, G. Alivizatos, J.J.M.C.H. de la Rosette. Interstitial Laser Coagulation (ILC) treatment in BPH: is it to be recommended? J Endourol; 17(8):595-600, 2003.

A.L. Hoffmann, M.P. Laguna Pes, J.J.M.C.H. de la Rosette, H. Wijkstra. Quantification of prostate shrinkage after microwave thermotherapy: a comparison of calculated Cell-Kill versus 3D transrectal ultrasound planimetry. Eur Urol; 43: 181-187, 2003.

S. Gravas, M.P. Laguna Pes, J.J.M.C.H. de la Rosette. Thermotherapy and thermoablation for benign prostatic hyperplasia. Curr Opin Urol; 13 : 45-49, 2003.

D.L. Floratos, J.L. Severens, L.A.L.M. Kiemeney, M.P. Laguna Pes, F.M. Debruyne, J.J.M.C.H. de la Rosette. Transurethral resection versus microwave thermotherapy of the prostate. A cost consequence analysis. BJU International; 92: 713-718, 2003.

B.W. Lagerveld, M.P. Laguna Pes, J.J.M.C.H. de la Rosette. Long term results after External Beam Radiation Therapy for T1-T2 localised prostate cancer. Current Urology Reports; 4:240-247, 2003.

S. Gravas, M.P. Laguna Pes, J.J.M.C.H. de la Rosette. Efficacy and safety of intraprostatic temperature controlled microwave thermotherapy in patients with benign prostatic hyperplasia: results of a prospective, open label, single center study with 1-year follow-up. J Endourol.; 17: 6:425-430, 2003.

G. Alivizatos, A. Skolarikos , M.P. Laguna Pes. Recent data upon impotence, incontinence and quality of life issues concerning radical prostatectomy. Arch Esp Urol.; 56: 321-330, 2003.

T.M. de Reijke, M.P. Laguna Pes. Long term complications of Brachytherapy. BJU International; 92: 869-873, 2003.

C.A. Mochtar, L.A.L.M. Kiemeney, M.M. van Riemsdijk, G.S. Barnet, M.P. Laguna Pes, F.M.J. Debruyne, J.J.M.C.H. de la Rosette. PSA as an estimator of prostate volume in the management of patients with symptomatic BPH. Eur. Urol.; 44: 65-700, 2003.

S. Gravas, M.P. Laguna Pes, J.J. de la Rosette. Application of external microwave thermotherapy in urology: past, present and future. J Endourol, 2003, 17: 659-666.

J.J.M.C.H. de la Rosette, M.P. Laguna Pes, S. Gravas, M.J.A.M. de Wildt. Transurethral Microwave Thermotherapy: the 'gold standard' for minimal invasive therapies in patients with Benign prostatic Hyperplasia (BPH). Jour. Endourol; 4: 245- 251, 2003.

2004:

R. Van Velthoven, A. Peltier, M.P. Laguna Pes, Th. Piechaud. Laparoscopic adenomectomy (Millin): pilot study on feasibility. Eur Urol.; 45: 103-109, 2004.

2005:

T. Skrekas, M.P. Laguna Pes, J.J.M.C.H. de la Rosette. Laparoscopic radical prostatectomy: A European virus. Minim Invasive Ther Allied Technol; 14(2): 98-103, 2005.

C.A. Mochtar, L.A.L.M. Kiemeney, M.P. Laguna Pes, M.M. Riemsdijk, G.S. Barnett, F.M.J. Debruyne, J.J.M.C.H. de la Rosette. The prognostic role of PSA and prostate volume for the risk of invasive therapy in BPH patients initially managed with alfa 1 blockers and watchful waiting. Urology; 65(2):300-5, 2005.

M.P. Laguna Pes, L.C. Schreuders, J.J. Rassweiler, C.C. Abbou, R. van Velthoven, G. Janetschek, G. Breda, J.J.M.C.H. de la Rosette. Development of laparoscopic surgery and training facilities in Europe: results of a survey of the European Society of Uro- Technology ( ESUT). Eur Urol.; 47: 346-351, 2005.

B.P.H. Schrier, M.P. Laguna Pes, F. van der Pal, S. Isorna Martinez de la Riva, J.A. Witjes. Comparison of orthotopic Sigmoid and Ileal neobladders: continence and urodynamic parameters. Eur Urol.; 47: 679-685, 2005.

B.W. Lagerveld, M.P. Laguna Pes, FM. Debruyne, JJ. de la Rosette. Holmium:YAG laser for treatment of strictures of the vesicourethral anastomosis after radical prostatectomy. J Endourol; 19: 497-501, 2005.

P.C. Kauer, M.P. Laguna Pes, G. Alivizatos, A. Joyce, R. Muschter, R. Swartz, D. Tolley and J.J.M.C.H. de la Rosette. Present practice and treatment strategies in endourological stone management. Results of a survey of the European Society of uro-technology (ESUT). Eur Urol, 8:182-188, 2005.

M.P. Laguna Pes, M. Brenninkmeijer, J.A. Belon, R. Marrero, H. Wijkstra, J.J.M.C.H. de la Rosette, S. Isorna. Long-term functional and urodynamic results of 50 patients receiving a modified sigmoid neobladder created with a short distal segment. J Urol; 174: 963-967, 2005.

S. Gravas, M.P. Laguna Pes, M. Ehrnebo, L. Wagrell, A. Matiasson, J.J.M.C.H. de la Rosette. Seeking for evidence that cell kill guided thermotherapy gives results not inferior to transurethral resection of prostate: results of a pooled analysis of 3 studies on feedback transurethral microwave thermotherapy. J Urol; 174:1002-1006, 2005.

P. Albers, W. Albrecht, F. Algaba, C. Bokemeyer, G. Cohn-Cedermark, A. Horwich, O. Klepp, M.P. Laguna Pes, G. Pizzocaro. Guidelines on testicular cancer. Eur Urol; 48: 885-894, 2005.

M.M. van Dijk, C.A. Mochtar, H. Wijkstra, M.P. Laguna Pes, J.J.M.C.H. de la Rosette. Hourglass-shaped nitinol prostatic stent in treatment of patients with lower urinary tract symptoms due to bladder outlet obstruction. Urology; 66: 845-849, 2005.

2006:

C.A. Mochtar, L.A. Kiemeney, M.P. Laguna Pes, F.M. Debruyne, J.J.M.C.H. de la Rosette. PSA velocity in conservatively managed BPH: Can it predict the need for BPH-related invasive therapy? Prostate; Jun 1, 2006.

J. Rassweiler, D. Teber, J.J.M.C.H. de la Rosette, M.P. Laguna Pes, V. Pansodoro, T. Frede. Laparoskopische beckenchirurgie. Wo stehen wir im jahr 2006? Urologe A; Aug 10, 2006.

S. Gravas, M.P.Laguna Pes, M. Melekos, J.J.M.C.H. de la Rosette. Current status of minimally invasive treatment for benign prostatic obstruction. Acta Urológica; 23 (1): 37-48, 2006.

K. Kijvikai, M. van Dijk, M.P. Laguna Pes, P. Lertsithichai, H. Wijkstra, J.J.M.C.H. de la Rosette. Clinical utility of “blind placement” prostatic stent in patients with benign prostatic obstruction: a prospective study. Urology 2006; 68(5):1025-30.

M.H. Wink, B.W. Lagerveld, M.P. Laguna Pes, J.J.M.C.H. de la Rosette, H. Wijkstra. Cryotherapy for renal-cell cancer: diagnosis, treatment and contrast enhanced ultrasonography for follow-up. J Endourol.; 20(7): 456-9, 2006.

T. Skrekas, C.A. Mochtar, B.W. Lagerveld, T.M. de Reijke, R.F. van Velthoven, J.J.M.C.H. de la Rosette, M.P. Laguna Pes. J. Mentor-initiated approach in laparoscopic radical prostatectomy. Endourol 2006; 20(10): 831-5.

M.P. Laguna Pes, N. Wondergem, M.H. Wink, H. Wijkstra, J. de la Rosette. Avances en el diagnóstico ecográfico del cancer de prostate. Arch. Esp. Urol. 2006; 59(10): 965-976.

C.A. Mochtar, L.A. Kiemeney, M.M. van Riemsdijk, M.P. Laguna Pes, F.M. Debruyne, J.J.M.C.H. de la Rosette de la Rosette. Post voidal residual urine is not a good predictor of the need for invasive therapy among patients with benign prostatic hyperplasia. J Urol; 175: 213-216, 2006.

M.P. Laguna Pes, A. Arce-Alcazar, C.A. Mochtar, R. Van Velthoven, A. Peltier, J.J.M.C.H. de la Rosette. Construct validity of the chicken model in the simulation of laparoscopic radical prostatectomy suture. J Endourol; 20: 69-73, 2006.

M.M. van Dijk, C.A.Mochtar, H. Wijkstra, M.P. Laguna Pes, J.J.M.C.H. de la Rosette. The bell- shaped nitinol prostatic stent in the treatment of lower urinary tract symptoms: experience in 108 patients. Eur Urol; 49::353-359, 2006.

M.P. Laguna Pes, T.M. de Reijke, H. Wijkstra, J.J.M.C.H. de la Rosette. Training in laparoscopic urology. Curr opin Urol; 16: 65-70, 2006.

M.P. Laguna Pes, F. Smedts, J. Nordling, T. Horn, K. Bouchelouche, A. Hopman, J.J.M.C.H. de la Rosette. Keratin expression profiling of transitional epithelium in the painful bladder syndrome/interstitial cystitis. Am J Clin Pathol; 125: 105-110, 2006.

K. Kijvikai, M.P. Laguna Pes, J.J.M.C.H. de la Rosette. Control of the large renal vein in limited dissected space during laparoscopic nephrectomy: a simple and reliable method. International Journal of Urology; 13: 851-853, 2006.

2007:

Haemostasis in laparoscopic partial nephrectomy: Current status. J.H. van Dijk, M.P. Laguna Pes. Minimally Invasive Therapy and Allied Technologies 2007; 16(1):31-44.

A. Breda, SV Stepanian, J. Liao , JS. Lam, G. Guazzoni, M. Stifelman, K. Perry, A. Celia, G. Breda, P. Fornara, S. Jackman, J. Palo, M. Grasso, V. Pansadoro, V. Disanto, F. Porpiglia, C. Milani, C. Abbou, R. Gaston, G. Janetschek, N.A. Soomro, J.J.M.C.H. De la Rosette, M.P. Laguna Pes, P.G. Schulam. Positive margins in laparoscopic partial nephrectomy in 855 cases: a multi-institutional survey from USA and Europe. Journal of Urology 2007;178(1):47-50.

A. Breda, S.V. Stepanian, J.S. Lam, J.C. Liao , I.S. Gill, J.R. Colombo, G. Guazzoni, K.T. Perry, A. Celia, G. Breda, P. Fornara, S.V. Jackman, A. Rosales, J. Palo, M. Grasso, V. Pansadoro, V. Disanto, F. Porpiglia, C. Milani, C. Abbou, R. Gaston, G. Janetschek, N.A. Soomro, J.J.M.C.H. De la Rosette, M.P. Laguna Pes, P.G. Schulam. Use of haemostatic agents and glues during laparoscopic partial nephrectomy: a multi-institutional survey from the United States and Europe of 1347 cases. Eur. Urol. 2007;52(3): 798-803.

M.M. Barendrecht, M. Oelke, M.P. Laguna Pes, M.C. Michel. Is the use of parasympathomimetics for treating an underactive urinary bladder evidence-based? BJU 2007; 99(4):749-52.

M.H. Wink, J.J.M.C.H. de la Rosette, M.P. Laguna Pes, B.W. Lagerveld, H. Wijkstra. Ultrasonography of renal masses using contrast pulse sequence imaging: a pilot study. J Endourol. 2007;21(5):466-72.

S. Gravas, M.P Laguna Pes, L.A. Kiemeney, J.J.M.C.H. de la Rosette. Durability of 30-minute high-energy transurethral microwave therapy for treatment of beningn prostatic hyperplasia: a study of 213 patients with and without urinary retention. Urology 2007 may; 69(5):854-8.

A. Skolarikos, G. Alivizatos, M.P. Laguna Pes, J.J.M.C.H. de la Rosette. A review on follow-up strategies for renal cell carcinoma after nephrectomy. European Urology 2007;51(6):1490-500.

M.H.Wink, M.P. Laguna, B.W. Lagerveld, J.J.M.C.H. de la Rosette, H.Wijkstra. Contrast-enhanced ultrasonography in the follow-up of cryoablation of renal tumours: a feasibility study. BJU Int 2007;99(6):1371-5.

M. Wink, M.P Laguna Pes, B.W. Lagerveld, J.J.M.C.H. de la Rosette, H. Wijkstra. Contrast-enhanced ultrasonography in the follow-up of cryoablation of renal tumours: a feasibility study. BJU int 2007 jun;99(6):1371-5.

S. Gravas, M.D. Melekos, M.P. Laguna Pes, J.J.M.C.H. de la Rosette. Evaluation of photoselective vaporization of the prostate. Aging Health 2007;3(6):723-730.

I.P. Kummerlin, J. Borrego, M.H. Wink, M.M. van Dijk, H. Wijkstra, J.J.M.C.H. de la Rosette, M.P. Laguna Pes. Nephron-sparing surgery and percutaneous biopsies in renal-cell carcinoma: a global impression among endourologists. J endourol. 2007;21(7):709-13.

C.A. Mochtar, P.C. Kauer, M.P. Laguna Pes, J.J.M.C.H. de la Rosette. Urinary leakage after laparoscopic radical prostatectomy: a systematic review. J endourol. 2007;21(11):1371-80.

2008:

I.H de Hingh, M.I van Berge-Henegouwen, M.P. Laguna Pes , O.R Busch, J.J. van Lanschot. Synchronous esophageal and renal cell carcinoma: incidence and possible treatment strategies. Dig Surg, 2008, 25 (1): 27 -31.

S. Krege, J. Beyer, R. Souchon, P. Albers, W. Albrecht, F. Algaba, M. Bamberg, I. Bodrogi, C. Bokemeyer, E. Cavallin-Ståhl, J. Classen, C. Clemm, G. Cohn-Cedermark, S. Culine, G. Daugaard, P.H. De Mulder, M. De Santis, M. de Wit, R. de Wit, H.G. Derigs, K.P. Dieckmann, A. Dieing, J.P. Droz, M. Fenner, K. Fizazi, A. Flechon, S.D, Fosså , X.G. del Muro, T. Gauler, L. Geczi, A. Gerl, J.R. Germa-Lluch, S. Gillessen, J.T. Hartmann, M. Hartmann, A. Heidenreich, W. Hoeltl, A. Horwich, R. Huddart, M. Jewett, J. Joffe, W.G. Jones, L. Kisbenedek, O. Klepp, S. Kliesch, K.U. Koehrmann, C. Kollmannsberger, M. Kuczyk, M.P. Laguna Pes, O.L. Galvis, V. Loy, M.D. Mason, G.M. Mead, R. Mueller, C. Nichols, N. Nicolai, T. Oliver, D. Ondrus, G.O. Oosterhof, L.P. Ares, G. Pizzocaro, J. Pont, T. Pottek , T. Powles, O. Rick, G. Rosti, R. Salvioni, J. Scheiderbauer, H.U. Schmelz , H. Schmidberger, H.J. Schmoll, M. Schrader, F. Sedlmayer, N.E. Skakkebaek, A. Sohaib, S. Tjulandin, P. Warde, S. Weinknecht, L. Weissbach, C.Wittekind, E. Winter, L. Wood, H. von der Maase. European consensus conference on diagnosis and treatment of germ cell cancer: a report of the second meeting of the European Germ Cell Cancer Consensus group(EGCCCG): part I. Eur Urol. 2008 Mar;53(3):478-96.

A. Celia, G. Zeccolini, G. Guazzoni, V. Pansadoro, V. Disanto, F. Porpiglia, C. Milani, C. Abbou, R. Gaston, G. Janetschek, N.A. Soomroo, P. Fornara, A. Breda, P.G. Schulam, J.J. de la Rosette, M.P. Laguna Pes, J. Palou, G. Breda. Laparoscopic nephron sparing surgery: a multi-institutional European survey of 592 cases. Arch Ital Urol Androl. 2008 Sep;80(3):85-91.

J.J. Rassweiler, W. Scheitlin, A. Heidenreich, M.P. Laguna Pes, G. Janetschek. Laparoscopic retroperitoneal lymph node dissection: does it still have a role in the management of clinical stage I nonseminomatous testis cancer? A European perspective. Eur Urol. 2008;54(4):1004-15.

J.J.M.C.H. de la Rosette, M.P. Laguna Pes, J.J. Rassweiler, P. Conort. Training in Percutaneous Nephrolithotomy-A Critical Review. Eur Urol. 2008;54(5): 994-1001.

J. Rioja, J.J.M.C.H. de la Rosette, H. Wijkstra, M.P. Laguna Pes. Curr. Opin. Advances in diagnosis and follow-up in kidney cancer. Urol. 2008: 18(5): 447-54.

I. Kümmerlin, F. Ten Kate, F. Smedts, T. Horn, F. Algaba, I. Trias, J.J.M.C.H. de la Rosette, M.P. Laguna Pes. Core Biopsies of Renal Tumors: A Study on Diagnostic Accuracy, Interobserver, and Intraobserver Variability. Eur Urol. 2008;53(6):1219-25.

A.M Bootsma, M.P. Laguna Pes, S.E. Geerlings, A. Goossens. Antibiotic prophylaxis in Urologic Procedures: a Systematic review. Eur Urol, 2008; 54(6):1270-86.

J.J. de la Rosette, J.R. Zuazu, P. Tsakiris, A.M. Elsakka, J.J. Zudaire, M.P. Laguna Pes, T.M. de Reijke. Prognostic factors and percutaneous nephrolithotomy morbidity: a multivariate analysis of a contemporary series using the clavien classification. J Urol 2008;180(6):2489-93.

I.P. Kummerlin, F.J. ten Kate, H. Wijkstra, J.J.M.C.H. de la Rosette, M.P. Laguna Pes. Changes in the stage and surgical management of renal tumours during 1995-2005: an analysis of the Dutch national histopathology registry. BJU Int. 2008;102(8): 946-51.

J. Rioja Zuazu, V. Totziaris, M.P. Laguna Pes, T.M. de Reijke, J.J.M.C.H. de la Rosette. Laser and bladder tumors. Arch Esp Urol 2008;61(9):994-1003.

P. Beemster, S. Phoa, H. Wijkstra, J.J.M.C.H. de la Rosette, M.P. Laguna Pes. Follow-up of renal masses after cryosurgery using computed tomography;enhancement patterns and cryolesion size. BJU int. 2008;101(10):1237-42.

I.P. Kümmerlin, F. Smedts, F.J. Ten Kate, T. Horn, F. Algaba, I. Trias, H. Wijkstra, J.J.M.C.H. de la Rosette, M.P. Laguna Pes. Cytological Punctures in the Diagnosis of Renal Tumours: A Study on Accuracy and Reproducibility. Eur Urol. 2008 May 7.

2009:

I.P. Kümmerlin, F. ten Kate, F. Smedts, T. Horn, F. Algaba, I. Trias, J.J.M.C.H. de la Rosette, M.P. Laguna Pes. Diagnostic problems in the subtyping of renal tumors encountered by five pathologists. Pathol Res Pract. 2009;205(1):27-34.

E. Ramos-Barcelo, J. Rioja, M.P. Laguna Pes, J.J.C.M.H. de la Rosette, T. de Reijke. Is age a prognostic factor for treatment outcome in renal cell cancer-a comprehensive review. Crit Rev Oncol Hematol 2009;72(1):83-9.

M.P. Laguna Pes, P. Beemster, V.Kumar, S. Wyler, C. Anderson, F.X. Keeley, A. Bachmann, J. Rioja, C. Mamoulakis, M. Marberger, J.J.M.C.H. de la Rosette. Perioperative morbidity of laparoscopic cryoablation of small renal masses with ultrathin probes: a European multicentre experience. Eur. Urol. 2009; 56(2):355-61.

M.M. van Dijk, M.A. van Dijk, H.Wijkstra, M.P. Laguna Pes, J.J.M.C.H. de la Rosette. The effect of temporary prostatic stent on sexual functioning. Central Eur J of Urol 2009;62(2):243-248.

P. Sountoulides, M.P. Laguna Pes, J.J.M.C.H. de la Rosette. Complications following augmentation cystoplasty; prevention and management. Central Eur J of Urol 2009;62(2): 216-221.

P. Tsakiris, P. Beemster, H. Wijkstra, J. de la Rosette, M.P. Laguna Pes. In vivo factors influencing the freezing cycle during cryoablation of small renal masses. J Endourol. 2009 Mar;23(3):545-9.

M.P. Laguna Pes, I. Kümmerlin, J. Rioja, J.J.M.C.H. de la Rosette. Biopsy of a renal mass: where are we now? Curr Opin Urol 2009;19(5):447-53.

A. Meissner, C. Mamoulakis, J.J.C.M.H. de la Rosette, M.P. Laguna Pes. Clinical update on testicular microlithiasis. Curr Opin Urol. 2009;19(6):615-8.

P.W. Beemster, I. Trias, F.J.W. ten Kate, F. Algaba, H. Wijkstra, J.J.M.C.H. de la Rosette, M.P. Laguna Pes. The diagnostic yield of immediate postcryoablation biopsies of small renal masses. J of Endourol 2009;23(7):1203-7.

R.C. Minnee, F.J. Bemelman, M.P. Laguna Pes, I.J. Ten Berge, D.A. Legemate, M.M. Idu. Effectiveness of a 5-Day External Stenting Protocol on Urological Complications after Renal Transplantation. World J Surg. 2009 Dec;33(12):2722-6.

H.J. Schmoll K. Jordan, R. Huddart, M.P. Laguna Pes, A. Horwich, K. Fizazi, V. Kataja; ESMO Guidelines Working Group. Testicular seminoma: ESMO clinical recommendations for diagnosis, treatment and follow-up. Ann Oncol. 2009 May; 20 Suppl 4:83-8.

M.P. Laguna Pes, T.M. de Reijke, J.J.M.C.H. de la Rosette. How far will simulators be involved into training. Current Urology Reports 2009;10:97-105.

H.J. Schmoll K. Jordan, R. Huddart, M.P. Laguna Pes, A. Horwich, K. Fizazi, V. Kataja; ESMO Guidelines Working Group. Testicular non-seminoma: ESMO clinical recommendations for diagnosis, treatment and follow-up. Ann Oncol. 2009 May; 20 Suppl 4:89-96.

2010:

B.W. Lagerveld, P. van Horssen, M.P. Laguna Pes, J.P. van den Wijngaard, G.J. Streekstra, J.J. de la Rosette, H. Wijkstra, J.A. Spaan. Immediate Effect of Kidney Cryoablation on Renal Arterial Structure in a Porcine Model Studied by Imaging Cryomicrotome. J Urol. 2010 Mar;183(3):1221-1226.

J. Rioja, V. Tzortzis, C. Mamoulakis, M.P. Laguna Pes. Cryotherapy for renal tumors: current status and contemporary developments. Actas Urol Esp. 2010Apr;34(4):309-17.

E.C. Cauberg, M.A. Salomons, I.P. Kümmerlin, T.M. de Reijke, A.H. Zwinderman, J.J.C.M.H. de la Rosette, F.J. Kate, M.P. Laguna Pes. Trends in epidemiology and treatment of upper urinary tract tumours in the Netherlands 1995-2005: an analysis of PALGA, the Dutch national histopathology registry. BJU Int. 2010 Apr;105(7):922-7.

H.J. Schmoll, K. Jordan, R. Huddart, M.P. Laguna Pes, A. Horwich, K. Fizazi, V. Kataja; ESMO Guidelines Working Group. Testicular seminoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2010 May;21 Suppl 5:v140-6.

H.J. Schmoll, K. Jordan, R. Huddart, M.P. Laguna Pes, A. Horwich, K. Fizazi, V. Kataja; ESMO Guidelines Working Group. Testicular non-seminoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2010 May;21 Suppl 5:v147-54.

A. Skolarikos, M.P. Laguna Pes, G. Alivizatos, A.R. Kural, J.J.C.M.H. de la Rosette. The role for active monitoring in urinary stones: a systematic review. J Endourol. 2010 Jun;24(6):923-30.

R. Autorino, G.P. Haber, R.J. Stein, A. Rane, M. De Sio, M.A. White, B. Yang, J.J.C.M.H. de la Rosette, J.H. Kaouk, M.P. Laguna Pes. Laparoscopic training in urology: critical analysis of current evidence. J Endourol. 2010 Sep;24(9):1377-90.

D.E. Zilberman, M.E. Lipkin, J.J.C.M.H. de la Rosette, M.N. Ferrandino, C. Mamoulakis, M.P. Laguna Pes, G.M. Preminger. Tubeless percutaneous nephrolithotomy--the new standard of care? J Urol. 2010 Oct;184(4):1261-6.

I.P. Kümmerlin, F.J. ten Kate, H. Wijkstra, A. Zwinderman, J.J.C.M.H. de la Rosette, M.P. Laguna Pes. A decade of surgically removed small renal masses in the Netherlands: characteristics and trends in type of surgery and pathologic reporting. J Endourol. 2010 Oct;24(10):1675-9.

P.W. Beemster, K. Barwari, C. Mamoulakis, H. Wijkstra, J.J.C.M.H. De La Rosette, M.P. Laguna Pes. Laparoscopic renal cryoablation using ultrathin 17-gauge cryoprobes: mid-term oncological and functional results. BJU Int. 2010 Nov 2.

2011:

J. Rioja, C. Mamoulakis, H. Sodha, S. Suwijn, M.P. Laguna Pes, J.J.C.M.H. de la Rosette. A plea for centralized care for ureteroscopy: results from a comparative study under different conditions within the same center. J Endourol. 2011 Mar;25(3):425-9.

B.W. Lagerveld, P. van Horssen, M.P. Laguna Pes, J.P. van den Wijngaard, M. Siebes, H. Wijkstra, J.J.C.M.H. de la Rosette, J.A. Spaan. Gradient changes in porcine renal arterial vascular anatomy and blood flow after cryoablation. J Urol. 2011 Aug;186(2):681-6.

P. Albers, W. Albrecht, F. Algaba, C. Bokemeyer, G. Cohn-Cedermark, K. Fizazi, A. Horwich, M.P. Laguna Pes. European Association of Urology. EAU guidelines on testicular cancer: 2011 update. Eur Urol. 2011 Aug;60(2):304-19.

P.W. Beemster, K. Barwari, C. Mamoulakis, H. Wijkstra, J.J.C.M.H. de la Rosette, M.P. Laguna Pes. Laparoscopic renal cryoablation using ultrathin 17-gauge cryoprobes: mid-term oncological and functional results. BJU Int. 2011 Aug;108(4):577-82.

K. Barwari, D.M. De Bruin, D.J. Faber, T.G. Van Leeuwen, J.J.C.M.H. De La Rosette, M.P. Laguna Pes. New optical diagnostic tools in renal cell cancer. Minerva Urol Nefrol. 2011 Sep;63(3):213-25.

A. Skolarikos, S. Gravas, M.P. Laguna Pes, O. Traxer, G.M. Preminger, J.J.C.M.H. de la Rosette. Training in ureteroscopy: a critical appraisal of the literature. BJU Int. 2011 Sep;108(6):798-805; discussion 805.

K. Barwari, P.W. Beemster, M.N. Hew, H. Wijkstra, J.J.C.M.H. de la Rosette, M.P. Laguna Pes. Are there parameters that predict a nondiagnostic biopsy outcome taken during laparoscopic-assisted cryoablation of small renal tumors? J Endourol. 2011 Sep;25(9):1463-8.

H. Van Poppel, F. Becker, J.A. Cadeddu, I.S. Gill, G. Janetschek, M.A. Jewett, M.P. Laguna Pes, M. Marberger, F. Montorsi, T.J. Polascik, O. Ukimura, G. Zhu. Treatment of localised renal cell carcinoma. Eur Urol. 2011 Oct;60(4):662-72.

M. Smeenge, M. Mischi, M.P. Laguna Pes , J.J. de la Rosette, H. Wijkstra. Novel contrast-enhanced ultrasound imaging in prostate cancer. World J Urol. 2011 Oct;29(5):581-7.

M.C. Rassweiler, C. Mamoulakis, H.G. Kenngott, J. Rassweiler, J.J.C.M.H. de la Rosette , M.P. Laguna Pes. Classification and detection of errors in minimally invasive surgery. J Endourol. 2011 Nov;25(11):1713-21.

E.C. Cauberg, C.Y. Nio, J.J.C.M.H. de la Rosette, M.P. Laguna Pes, Th.M. de Reijke. Computed tomography-urography for upper urinary tract imaging: is it required for all patients who present with hematuria? J Endourol. 2011 Nov;25(11):1733-40.

K. Barwari, D.M. de Bruin, E.C. Cauberg, D.J. Faber, T.G. van Leeuwen, H. Wijkstra, J.J.C.M.H. de la Rosette, M.P. Laguna Pes . Advanced diagnostics in renal mass using optical coherence tomography: a preliminary report. J Endourol 2011;25(2):311-5.

2012:

S. Gravas, V. Tzortzis, S.I. de la Riva, M.P. Laguna Pes , J.J.C.M.H. de la Rosette. Focal therapy for prostate cancer: patient selection and evaluation. Expert Rev Anticancer Ther. 2012 Jan;12(1):77-86.

E.R. Cordeiro, K. Barwari, A. Anastasiadis, M. García, F. Branco, J.J. De la Rosette, M.P. Laguna Pes . Laparoscopic cryotherapy for small renal masses: Current State. Arch Esp Urol. 2013 Jan;66(1):41-53. English, Spanish.

V.P. Alberts, R.C. Minnee, F.J. Bemelman, K.A. van Donselaar-van der Pant, M.P. Laguna Pes, Idu MM. Ureteral reconstruction after renal transplantation: clinical outcome and risk factors. Urol Int. 2012;88(3):333-7.

K. Barwari, J.J. de la Rosette, M.P. Laguna Pes. The penetration of renal mass biopsy in daily practice: a survey among urologists. J Endourol. 2012 Jun;26(6):737-47.

A. Skolarikos, M.P. Laguna Pes, J.J. de la Rosette. Conservative and radiological management of simple renal cysts: a comprehensive review. BJU Int. 2012 Jul;110(2):170-8.

P. Albers, W. Albrecht, F. Algaba, C. Bokemeyer, G. Cohn-Cedermark, K. Fizazi, A. Horwich, M.P. Laguna Pes. European Association of Urology. [EAU guidelines on testicular cancer: 2011 update. European Association of Urology]. Actas Urol Esp. 2012 Mar;36(3):127-45.

K. Barwari, D.M. de Bruin, D.J. Faber, T.G. van Leeuwen, J.J. de la Rosette, M.P. Laguna Pes . Differentiation between normal renal tissue and renal tumours using functional optical coherence tomography: a phase I in vivo human study. BJU Int. 2012 Oct;110(8 Pt B):E415-20.

K. Barwari, J.J.C.M.H. de la Rosette, M.P. Laguna Pes . The penetration of renal mass biopsy in daily practice: a survey among urologists. J Endourol. 2012 Jun;26(6):737-47.

A.C. Mues, R. Korets, J.A. Graversen, K. Badani, V. Bird, S.L. Best, J.A. Cadeddu, R. Clayman, E.M. McDougall, K. Barwari, M.P. Laguna Pes, J.J. de La Rosette, L.R. Kavoussi,Z. Okhunov, R. Munver, S.R. Patel, S.Y. Nakada, M. Tsivian, T.J. Polascik, A. Shalhav, W.B. Shingleton, E. Johnson, J.S. Wolf Jr, J. Landman. Clinical, Pathologic and Functional Outcomes after Nephron-Sparing Surgery in Patients with a Solitary Kidney: A Multi-center Experience. J Endourol. 2012 June 5.

M.N. Hew, R. Zonneveld, I.P. Kümmerlin, D. Opondo, J.J.C.M.H. de la Rosette, M.P. Laguna Pes. Age and gender related differences in renal cell carcinoma in a European cohort. J Urol. 2012 Jul;188(1):33-8.

M.N. Hew, R. Zonneveld, I.P. Kümmerlin, D. Opondo, J.J. de la Rosette, M.P. Laguna Pes. Age and gender related differences in renal cell carcinoma in a European cohort. J Urol. 2012 Jul;188(1):33-8.

A. Skolarikos, M.P. Laguna Pes, J.J.C.M.H. de la Rosette. Conservative and radiological management of simple renal cysts: a comprehensive review. BJU Int. 2012 Jul;110(2):170-8.

P.J. Zondervan, A.S. Gozen, D. Opondo, J.J. Rassweiler, J.J.C.M.H. de la Rosette, M.P. Laguna Pes. Partial nephrectomy: Is there an advantage of the self-retaining barbed suture in the perioperative period? A matched case-control comparison. World J Urol. 2012 Sep 6.

M.P. Laguna Pes, P.J. Zondervan, J.J.C.M.H. de la Rosette. Focal therapy in the management of small renal masses. Curr Opin Urol. 2012 Sep;22(5):372-8.

A.C. Mues, R. Korets, J.A. Graversen, K.K. Badani, VG Bird, S.L. Best, J.A. Cadeddu, R.V. Clayman, E. McDougall, K. Barwari, M.P. Laguna Pes, J.J.C.M.H. de la Rosette, L. Kavoussi, Z. Okhunov, R. Munver, S.R. Patel, S. Nakada, M. Tsivian, T.J. Polascik, A. Shalhav, W.B. Shingleton, E.K. Johnson, J.S. Wolf Jr, J. Landman. Clinical, Pathologic, and Functional Outcomes After Nephron-Sparing Surgery in Patients with a Solitary Kidney: A Multicenter Experience. J Endourol. 2012 Sep 6.

P.J. Zondervan, A.S. Gozen, D. Opondo, J.J. Rassweiler, J.J. de la Rosette, M.P. Laguna Pes. Partial nephrectomy: is there an advantage of the self-retaining barbed suture in the perioperative period? A matched case-control comparison. World J Urol. 2012 Oct;30(5):659-64.

K. Barwari, D.M. de Bruin, D.J. Faber, T.G. van Leeuwen, J.J.C.M.H. de la Rosette, M.P. Laguna Pes. Differentiation between normal renal tissue and renal tumours using functional optical coherence tomography: a phase I in vivo human study. BJU Int. 2012 Oct;110(8 Pt B):E415-20.

M.P. Laguna Pes. Re: under-grading of <4 cm renal masses on renal biopsy. J Urol. 2013 Feb;189(2):480.

M.P. Laguna Pes. Re: Validation of Serum Amyloid α as an Independent Biomarker for Progression-Free and Overall Survival in Metastatic Renal Cell Cancer Patients. J Urol. 2013 Mar;189(3):840-1.

P. Gontero, S. Joniau, M. Oderda, M. Ruutu, H. Van Poppel, M.P. Laguna Pes, J.J. de la Rosette, Z. Kirkali. Active surveillance for small renal tumors: Have clinical concerns been addressed so far? Int J Urol. 2012 Nov 6.

E. Montanari, J.J. de la Rosette, F. Longo, A. Del Nero, M.P. Laguna Pes. Narrow-band imaging (NBI) and white light (WLI) transurethral resection of the bladder in the treatment of non-muscle-invasive bladder cancer. Arch Ital Urol Androl. 2012 Dec;84(4):179-83.

M. Cosentino, A. Breda, F. Sanguedolce, J. Landman, J.U. Stolzenburg, P. Verze, J. Rassweiler, H. Van Poppel, H.C. Klingler, G. Janetschek, A. Celia, F.J. Kim, G. Thalmann , U. Nagele, A. Mogorovich, C. Bolenz, T. Knoll, F. Porpiglia, M. Alvarez-Maestro, F. Francesca, F. Deho, S. Eggener, C. Abbou, M.V. Meng, M. Aron,

M.P Laguna Pes, D. Mladenov , A. D'Addessi, P. Bove, R. Schiavina, O. De Cobelli, A.S. Merseburger, O. Dalpiaz, F.C. D'Ancona, T.J. Polascik, R. Muschter, T.J. Leppert, H. Villavicencio. The use of mannitol in partial and live donor nephrectomy: an international survey. World J Urol. 2012 Dec 15.

M.P. Laguna Pes. Re: importance of cosmesis to patients undergoing renal surgery: a comparison of Laparoendoscopic Single-Site (LESS), laparoscopic and open surgery.J Urol. 2013 Feb;189(2):481.

2013:

K. Barwari, H. Wijkstra, O.M. van Delden, J.J. de la Rosette, M.P. Laguna Pes. Contrast-Enhanced Ultrasound for the Evaluation of the Cryolesion After Laparoscopic Renal Cryoablation: An Initial Report. J Endourol. 2013 Jan 15.

E.R. Cordeiro, K. Barwari, A. Anastasiadis, M. García, F. Branco, J.J. De la Rosette, M.P. Laguna Pes. Laparoscopic cryotherapy for small renal masses: Current State. Arch Esp Urol. 2013 Jan;66(1):41-53. English, Spanish.

M.N. Hew, P. Zondervan, S. Guven, J.J. De La Rosette, M.P. Laguna Pes. Prognostic models and factors for patients with renal cell carcinoma; a survey on their use amongst urologists. J Endourol. 2013 Feb 4.

M.P. Laguna Pes. Re: importance of cosmesis to patients undergoing renal surgery: a comparison of Laparoendoscopic Single-Site (LESS), laparoscopic and open surgery. J Urol. 2013 Feb;189(2):481.

M.P. Laguna Pes. Re: under-grading of <4 cm renal masses on renal biopsy. J Urol. 2013 Feb;189(2):480.

G. Verhoest, J. Patard, E. Oger, N. Rioux-Leclercq, B. Peyronnet, T. Bessède, M.P. Laguna Pes, K. Barwari, J. Rigaud, M. Roupret, G. Coffin, J. Bernhard, J. Long, A. Zisman, J. Berger, P. Paparel, C. Maurin, E. Lechevallier, R. Bertini, I. Ouzaid, L. Salomon, A. Bex, R. Farfara, B. Ljungberg, A.R. Rodriguez, K. Bensalah. Predictive factors of chronic kidney disease stage V after partial nephrectomy in a solitary kidney: a multi-institutional study. Urol Oncol. 2013 Feb 18.

M.P. Laguna Pes. Re: validation of serum amyloid α as an independent biomarker for progression-free and overall survival in metastatic renal cell cancer patients. J Urol. 2013 Mar;189(3):840-1.

M.P. Laguna Pes. Re: under-grading of <4 cm renal masses on renal biopsy. J Urol. 2013 Feb;189(2):480.

S. Houtzager, H. Wijkstra, J.J. de la Rosette, M.P. Laguna Pes. Evaluation of renal masses with contrast-enhanced ultrasound. Curr Urol Rep. 2013 Apr;14(2):116-23.

P. Gontero, S. Joniau, M. Oderda, M. Ruutu, H. Van Poppel H, M.P. Laguna Pes, J.J.M.C.H. de la Rosette, Z. Kirkali. Active surveillance for small renal tumors: have clinical concerns been addressed so far? Int J Urol. 2013 Apr;20(4):356-61.

J. Beyer, P. Albers, R. Altena, J. Aparicio, C. Bokemeyer, J. Busch, R. Cathomas, E. Cavallin-Stahl, N.W. Clarke, J. Claßen, G. Cohn-Cedermark, A. Dahl, G. Daugaard, U. de Giorgi, M. de Santis, M. de Wit, R. de Wit, K. Dieckmann, M. Fenner, K. Fizazi, A. Flechon, S.D. Fossa, J. Germá Lluch, J. Gietema, S. Gillessen, A. Giwercman, J. Hartmann, A. Heidenreich, M. Hentrich, F. Honecker, A. Horwich, R. Huddart, S. Kliesch, C. Kollmannsberger, S. Krege, M.P. Laguna Pes, L. Looijenga, A. Lorch, J. Lotz, F. Mayer, A. Necchi, N. Nicolai, J. Nuver, K. Oechsle, J. Oldenburg, J. Oosterhuis, T. Powles, E. Rajpert-De Meyts, O. Rick, G. Rosti, R. Salvioni, M. Schrader, S. Schweyer, F. Sedlmayer, A. Sohaib, R. Souchon, T. Tandstad, C. Winter, C. Wittekind. Maintaining success, reducing treatment burden, focusing on survivorship: highlights from the third European consensus conference on diagnosis and treatment of germ-cell cancer. Ann Oncol. 2013 Apr;24(4):878-88.

M.P. Laguna Pes. Re: systematic review of perioperative and quality-of-life outcomes following surgical management of localised renal cancer. J Urol. 2013 May;189(5):1693-4.

M.P. Laguna Pes. Are we ready for molecular imaging-guided surgery? Eur Urol. 2014 May;65(5):965-6.

M.P. Laguna Pes. Re: limitations of preoperative biopsy in patients with metastatic renal cell carcinoma: comparison to surgical pathology in 405 cases. J Urol. 2013 May;189(5):1692-3.

M.P. Laguna Pes. Re: Comparison of oncological outcomes after segmental ureterectomy or radical nephroureterectomy in urothelial carcinomas of the upper urinary tract: results from a large French multicentre study. J Urol. 2013 Jun;189(6):2087-8.

M.P. Laguna Pes. Re: Ureteroscopic and extirpative treatment of upper urinary tract urothelial carcinoma: a 15-year comprehensive review of 160 consecutive patients. J Urol. 2013 Jun;189(6):2088-9.

M.P. Laguna Pes. Re: regional differences in practice patterns and associated outcomes for upper tract urothelial carcinoma in Canada. J Urol. 2013 Jul;190(1):61.

J. Rassweiler, M.P. Laguna Pes, P. Chlosta, V. Pansadoro, F. Gaboardi, J. Stolzenburg, E. Barret, E. Liatiskos, L. Tunc, T. Frede, H. John, A. Bachmann, R. van Velthoven. ESUT Expert Group on Laparoscopy Proposes Uniform Terminology During Radical Prostatectomy: We Need to Speak the Same Language. Eur Urol. 2013 Jul;64(1):97-100.

M.N. Hew, P.J. Zondervan, S. Guven, J.J.M.C.H. de la Rosette, M.P. Laguna Pes. Prognostic models and factors for patients with renal-cell carcinoma: a survey on their use among urologists. J Endourol. 2013 Jun;27(6):790-9.

M.P. Laguna Pes. Re: Ureteroscopic and extirpative treatment of upper urinary tract urothelial carcinoma: a 15-year comprehensive review of 160 consecutive patients. J Urol. 2013 Jun;189(6):2088-9.

M.P. Laguna Pes. Re: positron emission tomography/computed tomography identification of clear cell renal cell carcinoma: results from the REDECT trial. J Urol. 2013 Aug;190(2):493.

M.P. Laguna Pes. Re: Long-term oncologic outcomes after radiofrequency ablation for T1 renal cell carcinoma. J Urol. 2013 Oct;190(4):1205-6.

K. Barwari, I.P. Kummerlin, F.J. ten Kate, F. Algaba, I. Trias, H. Wijkstra, J.J.M.C.H. De la Rosette, M.P. Laguna Pes. What is the added value of combined core biopsy and fine needle aspiration in the diagnostic process of renal tumours? World J Urol. 2013 Aug;31(4):823-7.

M.P. Laguna Pes. Re: Ipsilateral adrenalectomy at the time of radical nephrectomy impacts overall survival. J Urol. 2013 Oct;190(4):1205.

M.P. Laguna Pes. Re: Significant variability in 10-year cumulative radiation exposure incurred on different surveillance regimens after surgery for pT1 renal cancers: yet another reason to standardize protocols? J Urol. 2013 Nov;190(5):1711.

V.P. Alberts, R.C. Minnee, K.A. van Donselaar-van der Pant, F.J. Bemelman, P.J. Zondervan, M.P. Laguna Pes, Idu MM. Duplicated ureters and renal transplantation: a case-control study and review of the literature. Transplant Proc. 2013 Nov;45(9):3239-44.

M.P. Laguna Pes. Re: Illness uncertainty and quality of life of patients with small renal tumors undergoing watchful waiting: a 2-year prospective study. J Urol. 2013 Nov;190(5):1710.

M.P. Laguna Pes. Re: Impact of smoking on oncologic outcomes of upper tract urothelial carcinoma after radical nephroureterectomy. J Urol. 2013 Dec;190(6):2017-8.

M.P. Laguna Pes. Re: A randomised, double-blind phase III study of pazopanib in patients with advanced and/or metastatic renal cell carcinoma: final overall survival results and safety update. J Urol. 2013 Dec;190(6):2017.

F.T. Furriel, M.P. Laguna Pes, Figueiredo AJ, Nunes PT, Rassweiler JJ. Training of European urology residents in laparoscopy: results of a pan-European survey. BJU Int. 2013 Dec;112(8):1223-8.

2014:

M.P. Laguna Pes. Re: carbonic anhydrase IX (CAIX) is not an independent predictor of outcome in patients with clear cell renal cell carcinoma (ccRCC) after long-term follow-up. J Urol. 2014 Jan;191(1):54-5.

M.P. Laguna Pes. Re: an investigation of risk factors for renal cell carcinoma by histologic subtype in two case-control studies. J Urol. 2014 Jan;191(1):55.

M.P. Laguna Pes. Re: parenchymal volume preservation and ischemia during partial nephrectomy: functional and volumetric analysis. J Urol. 2014 Feb;191(2):347.

M.P. Laguna Pes. Re: overall survival advantage with partial nephrectomy: a bias of observational data? J Urol. 2014 Feb;191(2):346-7.

P.G. Wagstaff, A. Ingels, P.J. Zondervan, J.J. de la Rosette, M.P. Laguna Pes. Thermal ablation in renal cell carcinoma management: a comprehensive review. Curr Opin Urol. 2014 Sep;24(5):474-82.

P.G. Wagstaff, P.J. Zondervan, J.J.M.C.H. de la Rosette, M.P. Laguna Pes. The role of imaging in the active surveillance of small renal masses. Curr Urol Rep. 2014 Mar;15(3):386.

M.P. Laguna Pes. Re: everolimus for angiomyolipoma associated with tuberous sclerosis complex or sporadic lymphangioleiomyomatosis (EXIST-2): a multicentre, randomised, double-blind, placebo-controlled trial. J Urol. 2014 Mar;191(3):626-7.

M.P. Laguna Pes. Re: Cumulative incidence of cancer after solid organ transplantation. J Urol. 2014 Apr;191(4):948-9.

M.P. Laguna Pes. Re: Features associated with recurrence beyond 5 years after nephrectomy and nephron-sparing surgery for renal cell carcinoma: development and internal validation of a risk model (PRELANE score) to predict late recurrence based on a large multicenter database (CORONA/SATURN project). J Urol. 2014 Apr;191(4):949.

M.P. Laguna Pes. Re: management of localized kidney cancer: calculating cancer-specific mortality and competing risks of death for surgery and nonsurgical management. J Urol. 2014 May;191(5):1262-3.

M.N. Hew, D. Opondo, E.R. Cordeiro, K.A. van Donselaar-van der Pant, F.J. Bemelman, M.M. Idu, J.J.M.C.H. de la Rosette, M.P. Laguna Pes. The 1-year decline in estimated glomerular filtration rate (eGFR) after radical nephrectomy in patients with renal masses and matched living kidney donors is the same. BJU Int. 2014 May;113(5b):E49-55.

M. Tsivian, E.N. Rampersau Jr, M.P. Laguna Pes, S. Joniau, R.J. Leveillee, W.B. Shingleton, M. Aron, C.Y. Kim, A.M. DeMarzo, M.M. Desai, J.D. Meler, J.F. Donovan, H.C. Klingler, D.R. Sopko, J.F. Madden, M. Marberger, M.N. Ferrandino, T.J. Polascik. Small renal mass biopsy--how, what and when: report from an international consensus panel. BJU Int. 2014 Jun;113(6):854-63.

M.P. Laguna Pes, F. Algaba, J. Cadeddu, R. Clayman, I. Gill, G. Gueglio, M. Hohenfellner, A. Joyce, J. Landman, B. Lee, H. van Poppel. Clinical Research Office of the Endourological Society Renal Mass Study. Current patterns of presentation and treatment of renal masses: a clinical research office of the endourological society prospective study. J Endourol. 2014 Jul;28(7):861-70.

M. Westendarp, M.P. Laguna Pes, J.J.M.C.H. de la Rosette. [Diagnosis of upper urinary tract tumors. A pending challenge]. Arch Esp Urol. 2014 Jul;67(6):521-8. Spanish.

M.P. Laguna Pes. Re: Renal function after nephron-sparing surgery versus radical nephrectomy: results from EORTC randomized trial 30904. J Urol. 2014 Aug;192(2):369-70.

M.P. Laguna Pes. Re: Prognostic significance of venous tumour thrombus consistency in patients with renal cell carcinoma (RCC). J Urol. 2014 Aug;192(2):370.

M.P. Laguna Pes. Re: the predictive value of C-reactive protein for prognosis in patients with upper tract urothelial carcinoma treated with radical nephroureterectomy: a multi-institutional study. J Urol. 2014 Sep;192(3):722.

M.P. Laguna Pes. Re: defining early-onset kidney cancer: implications for germline and somatic mutation testing and clinical management. J Urol. 2014 Sep;192(3):721-2.

P.G. Wagstaff, A. Ingels, P.J. Zondervan, J.J. de la Rosette, M.P. Laguna Pes. Thermal ablation in renal cell carcinoma management: a comprehensive review. Curr Opin Urol. 2014 Sep;24(5):474-82.

V.P. Alberts, M.M. Idu, D.A. Legemate, M.P. Laguna Pes, R.C. Minnee. Ureterovesical anastomotic techniques for kidney transplantation: a systematic review and meta analysis. In: Transplant International 2014 Jun;27(6):593-605 27(6), 2014, p.593 605.

P.G. Wagstaff, A. Ingels, P.J. Zondervan, J.J. de la Rosette, M.P. Laguna. Thermal ablation in renal cell carcinoma management: a comprehensive review. Curr Opin Urol. 2014 Sep;24(5):474-82.

W. van den Bos, D.M. de Bruin, B.G. Muller, I.M. Varkarakis, A.A. Karagiannis, P.J. Zondervan, M.P. Laguna Pes, D.P. Veelo, C.D. Savci Heijink, M.R. Engelbrecht, H. Wijkstra, Th.M. de Reijke, J.J.M.C.H. de la Rosette. The safety and efficacy of irreversible electroporation for the ablation of prostate cancer: a multicentre prospective human in vivo pilot study protocol. BMJ Open. 2014 Oct 29;4(10):e006382.

R.Bahi, G. Pignot, Y. Hammoudi, K. Bensalah, E. Oger, M.P. Laguna Pes, K. Barwari, T. Bessède, J. Rigaud, M. Roupret, J.C. Bernhard, J.A. Long , A. Zisman, J. Berger, P. Paparel, E. Lechevallier, R. Bertini, L. Salomon, A. Bex, R. Farfara, B. Ljungberg, A.R. Rodriguez, J.J. Patard. Ischemia is not an independent predictive factor of chronic renal failure after partial nephrectomy in a solitary kidney in patients without pre-operative renal insufficiency. Prog Urol. 2014 Oct 23. pii: S1166-7087(14)00544-2.

M. Westendarp, M.P. Laguna Pes, J.J.M.C.H. de la Rosette. Diagnosis of upper urinary tract tumors. A pending challenge. Arch Esp Urol. 2014 Jul;67(6):521-8. Spanish.

2015:

T. Bach, R. Muschter, T.R. Herrmann, T. Knoll, C.M. Scoffone, M.P. Laguna Pes, A. Skolarikos, P. Rischmann, G. Janetschek, J.J.M.C.H. De la Rosette, U. Nagele, B. Malavaud, A. Breda, J. Palou, A. Bachmann, T. Frede, P. Geavlete, E. Liatsikos, P. Jichlinski, H.E. Schwaibold, P. Chlosta, A.G. Martov, A. Lapini, J. Schmidbauer, B. Djavan, A. Stenzl, M. Brausi, J.J. Rassweiler. Technical solutions to improve the management of non-muscle-invasive transitional cell carcinoma: summary of a European Association of Urology Section for Uro-Technology (ESUT) and Section for Uro-Oncology (ESOU) expert meeting and current and future perspectives. BJU Int. 2015 Jan;115(1):14-23.

M.P. Laguna Pes. Re: Quality Assessment of Partial Nephrectomy Complications Reporting Using EAU Standardised Quality Criteria. J Urol. 2015 Mar;193(3):783.

M.P. Laguna Pes. Re: Extent of lymph node dissection at nephrectomy affects cancer-specific survival and metastatic progression in specific sub-categories of patients with renal cell carcinoma (RCC). J Urol. 2015 Feb;193(2):457.

M.T. Bus, D.M. de Bruin, D.J. Faber, G.M. Kamphuis, P.J. Zondervan, M.P. Laguna Pes, Th.M. de Reijke, O. Traxer, T.G. van Leeuwen, J.J.M.C.H. de la Rosette. Optical diagnostics for upper urinary tract urothelial cancer: technology, thresholds, and clinical applications. J Endourol. 2015 Feb;29(2):113-23.

J.J.M.C.H. de la Rosette, M.P. Laguna Pes. Ureteric colic: evidence empowers responsible treatment. Lancet. 2015 May 18. pii: S0140-6736(15)60965-5.

M. Westendarp, A. Postema, J.J.M.C.H. de la Rosette, H. Wijkstra, M.P. Laguna Pes. [Advances in ultrasound techniques for the diagnosis and staging of prostate cancer. Elastography, Doppler ultrasound, ultrasound contrast media, ultrasound quantification media and MRI fusion]. Arch Esp Urol. 2015 Apr;68(3):307-15. Spanish.

P.G. Wagstaff, D.M. de Bruin, P.J. Zondervan, C.D. Savci Heijink, M.R. Engelbrecht, O.M. van Delden, T.G. van Leeuwen, H. Wijkstra, J.J.M.C.H. de la Rosette, M.P. Laguna Pes. The efficacy and safety of irreversible electroporation for the ablation of renal masses: a prospective, human, in-vivo study protocol. BMC Cancer. 2015 Mar 22;15:165.

P.G. Wagstaff, A. Swaan, A. Ingels, P.J. Zondervan, O.M. van Delden, D.J. Faber, T.G. van Leeuwen, J.J.M.C.H. de la Rosette, D.M. de Bruin, M.P. Laguna Pes. In vivo, percutaneous, needle based, optical coherence tomography of renal masses. J Vis Exp. 2015 Mar 30;(97).

P.G. Wagstaff, D.M. de Bruin, W. van den Bos, A. Ingels, M.J. van Gemert, P.J. Zondervan, R.M. Verdaasdonk, K.P. van Lienden, T.G. van Leeuwen, J.J.M.C.H. de la Rosette, M.P. Laguna Pes. Irreversible electroporation of the porcine kidney: Temperature development and distribution. Urol Oncol. 2015 Apr;33(4):168.e1-7.

M.P. Laguna Pes. Re: Renal tumor contact surface area: a novel parameter for predicting complexity and outcomes of partial nephrectomy. J Urol. 2015 May;193(5):1515.

M.P. Laguna Pes. Re: comparison of radiation dose from conventional and triple-bolus computed tomography urography protocols in the diagnosis and management of patients with renal cortical neoplasms. J Urol. 2015 Jun;193(6):1929.

M.P. Laguna Pes. Re: Cytoreductive nephrectomy in patients with synchronous metastases from renal cell carcinoma: results from the International Metastatic Renal Cell Carcinoma Database Consortium. J Urol. 2015 May;193(5):1514-5.

M.P. Laguna Pes. Re: Internal validation of the renal pelvic score: a novel marker of renal pelvic anatomy that predicts urine leak after partial nephrectomy. J Urol. 2015 Apr;193(4):1151-2.

M.P. Laguna Pes. Re: Hereditary-like urothelial carcinomas of the upper urinary tract benefit more from adjuvant cisplatin-based chemotherapy after radical nephroureterectomy than do sporadic tumours. J Urol. 2015 Jan;193(1):72.

M.P. Laguna Pes. Re: ClearCode34: a prognostic risk predictor for localized clearcell renal cell carcinoma. J Urol. 2015 Jan;193(1):71-2.

W. van den Bos, D.M. de Bruin, R.R. Jurhill, C.D. Savci-Heijink , B.G. Muller, I.M. Varkarakis, A. Skolarikos, P.J. Zondervan, M.P. Laguna-Pes, H. Wijkstra, Th.M. de Reijke, J.J.M.C.H. de la Rosette . The correlation between the electrode configuration and histopathology of irreversible electroporation ablations in prostate cancer patients. World J Urol. 2015 Aug 22.

W. van den Bos, B.G. Muller, D.M. de Bruin, A.L. de Castro Abreu , C. Chaussy, J.A. Coleman, A. Finelli, I.S. Gill, M. E. Gross, S.F. Jenniskens, F. Kahmann, M.P. Laguna Pes, A.R. Rastinehad, L.A. Simmons, T. Sulser, A. Villers, J.F. Ward, J.J.M.C.H. de la Rosette. Salvage ablative therapy in prostate cancer: International multidisciplinary consensus on trial design. Urol Oncol. 2015 Jul 28. pii: S1078-1439(15)00324-5.

M.P. Laguna Pes. Re: Perioperative Outcomes of 6042 Nephrectomies in 2012: Surgeon-Reported Results in the UK from the British Association of Urological Surgeons (BAUS) Nephrectomy Database. J Urol. 2015 Jul;194(1):42-3.

B.G. Muller, D.M. de Bruin, W. van den Bos, M.J. Brandt, J.F. Velu, M.T. Bus, D.J. Faber,D. Savci, P.J. Zondervan, Th.M. de Reijke, M.P. Laguna Pes, J.J.M.C.H. de la Rosette, T.G. van Leeuwen. Prostate cancer diagnosis: the feasibility of needle-based optical coherence tomography. J Med Imaging (Bellingham). 2015 Jul;2(3):037501.

M.P. Laguna Pes. Re: Evaluation of the National Comprehensive Cancer Network and American Urological Association Renal Cell Carcinoma Surveillance Guidelines. J Urol. 2015 Jul;194(1):43.

M.P. Laguna Pes. Re: Comparison of Partial Nephrectomy and Percutaneous Ablation for cT1 Renal Masses. J Urol. 2015 Aug;194(2):331-2.

M.P. Laguna Pes. Re: Impact of Warm versus Cold Ischemia on Renal Function following Partial Nephrectomy. J Urol. 2015 Aug;194(2):332.

M.P. Laguna Pes. What matters when selecting candidates for renal ablation: tumor size or the patient's condition? Cent European J Urol. 2015;68(2):137-8.

M.P. Laguna Pes. Re: Benefit in Regionalization of Care for Patients Treated with Nephrectomy: A Nationwide Inpatient Sample. J Urol. 2015 Sep;194(3):664-5.

M.P. Laguna Pes. Re: Evaluation of Functional Outcomes after Laparoscopic Partial Nephrectomy Using Renal Scintigraphy: Clamped vs Clampless Technique. J Urol.2015 Oct;194(4):953.

P. Albers, W. Albrecht, F. Algaba, C. Bokemeyer, G. Cohn-Cedermark, K. Fizazi, A. Horwich, Laguna Pes, N. Nicolai, J. Oldenburg . Guidelines on Testicular Cancer: 2015 Update. Eur Urol. 2015 Aug 18. pii: S0302-2838(15)00703-4.

M.P. Laguna Pes. Re: International Variations and Trends in Renal Cell Carcinoma Incidence and Mortality. J Urol. 2015 Oct;194(4):950-

P. Zondervan, K.P. Van Lienden, O.M. van Delden, J.J.M.C.H. De La Rosette, P. Laguna Pes. Preoperative Decision Making for Nephron Sparing Procedure in the Renal Mass :Time for Using Standard Tools? J Endourol. 2015 Sep 28.

W. van den Bos, D.M. de Bruin, A. van Randen, M.R. Engelbrecht, A.W. Postema, B.G. Muller, I.M. Varkarakis, A. Skolarikos, C.D. Savci-Heijink, R.R. Jurhill, P.J. Zondervan, M.P. Laguna Pes, H. Wijkstra, T.M. de Reijke, J.J.M.C.H. de la Rosette. MRI and contrast-enhanced ultrasound imaging for evaluation of focal irreversible electroporation treatment: results from a phase I-II study in patients undergoing IRE followed by radical prostatectomy. Eur Radiol. 2015 Oct 8.

M. Westendarp, A. Postema, J.J.M.C.H. de la Rosette, H. Wijkstra, M.P. Laguna Pes: Avances en las Técnicas Ecográficas para el diagnóstico y estadiaje del cáncer de próstata. Elastografía, Ecografía doppler, Contrastes Ecográficos, Métodos de Cuantificación ecográfica y fusión con Resonancia Magnética Nuclear. In: ARCHIVOS ESPANOLES DE UROLOGIA 68(3), 2015, p.307-315.

P.G. Wagstaff, A. Ingels, D.M. de Bruin, M. Buijs, P.J. Zondervan, C.D. Savci Heijink, O.M. van Delden, D.J. Faber, T.G. van Leeuwen, R. J. van Moorselaar, J.J.M.C.H. de la Rosette, M.P. Laguna Pes. Percutaneous Needle Based Optical Coherence Tomography for the Differentiation of Renal Masses: a Pilot Cohort. J Urol. 2015 Dec 21. pii: S0022-5347(15)05510-X.

M.M. Fockens, V.P. Alberts, F.J. Bemelman, M.P. Laguna Pes, M.M. Idu. Internal or External Stenting of the Ureterovesical Anastomosis in Renal Transplantation. Urol Int. 2016;96(2):152-6.

M.P. Laguna Pes. Re: Risk Stratification for Bladder Recurrence of Upper Urinary Tract Urothelial Carcinoma after Radical Nephroureterectomy. J Urol. 2015 Dec;194(6):1582-3.

M.P. Laguna Pes. Re: Subcentimeter Pulmonary Nodules Are Not Associated with DiseaseProgression in Patients with Renal Cell Carcinoma. Eur Urol. 2015 Nov;68(5):908.

A. Cicione, R. Autorino, M.P. Laguna Pes, M. De Sio, S. Micali, B. Turna, R. Sanchez-Salas, C. Quattrone, E. Dias, P. Mota, G. Bianchi, R. Damano, J. Rassweiler, E. Lima. Three-dimensional Technology Facilitates Surgical Performance of Novice Laparoscopy Surgeons: A Quantitative Assessment on a Porcine Kidney Model. Urology. 2015 Jun;85(6):1252-6.

M.P. Laguna Pes. Re: Comparison of radiation dose from conventional and triple-bolus computed tomography urography protocols in the diagnosis and management of patients with renal cortical neoplasms. J Urol. 2015 Jun;193(6):1929.

2016:

M.P. Laguna Pes. Re: Health Economic Changes as a Result of Implementation of Targeted Therapy for Metastatic Renal Cell Carcinoma: National Results from DARENCA Study 2. J Urol. 2016 Mar;195(3):608-9.

M.P. Laguna Pes. Re: Trifecta and Optimal Perioperative Outcomes of Robotic and Laparoscopic Partial Nephrectomy in Surgical Treatment of Small Renal Masses: A Multi-Institutional Study. J Urol. 2016 Feb;195(2):298.

M.P. Laguna Pes. Re: Five-Year Analysis of a Multi-Institutional Prospective Clinical Trial of Delayed Intervention and Surveillance for Small Renal Masses: The DISSRM Registry. J Urol. 2016 Feb;195(2):297-8.

M.P. Laguna Pes. Re: Clinical and Radiographic Predictors of the Need for Inferior Vena Cava Resection during Nephrectomy for Patients with Renal Cell Carcinoma and Caval Tumour Thrombus. J Urol. 2016 Mar;195(3):609.

M.P. Laguna Pes. Re: Novel Kidney Segmentation System to Describe Tumour Location for Nephron-Sparing Surgery. J Urol. 2016 Jan;195(1):61.

M.P. Laguna Pes. Re: Interobserver Variability of R.E.N.A.L., PADUA, and Centrality Index Nephrometry Score Systems. J Urol. 2016 Jan;195(1):60-1.

B.G. Muller,D.M. de Bruin, M.J. Brandt, W. van den Bos, S. van Huystee, D.J. Faber, D. Savci, P.J. Zondervan, Th.M. de Reijke, M.P. Laguna Pes, T.G. van Leeuwen, J.J.M.C.H. de la Rosette. Prostate cancer diagnosis by optical coherence tomography: First results from a needle based optical platform for tissue sampling. J Biophotonics. 2016 Feb 9.

A. Ingels, M. Hew, F. Algaba, O.J. de Boer, R.J. van Moorselaar, S. Horenblas, P. Zondervan, J.J.M.C.H. de la Rosette, M.P. Laguna Pes. Vimentin over-expression and carbonic anhydrase IX under-expression are independent predictors of recurrence, specific and overall survival in non-metastatic clear-cell renal carcinoma: a validation study. World J Urol. 2016 May 20.

M.J. Scheltema, W. van den Bos, D.M. de Bruin, H. Wijkstra, M.P. Laguna Pes, Th.M. de Reijke, J.J.M.C.H. de la Rosette. Focal vs extended ablation in localized prostate cancer with irreversible electroporation; a multi-center randomized controlled trial. BMC Cancer. 2016 May 5;16(1):299.

P.J. Zondervan, P.G. Wagstaff, M.M. Desai, D.M. de Bruin, A.F. Fraga, B.A. Hadaschik, J. Köllermann, U.B. Liehr, S.A. Pahernik, H.P. Schlemmer, J.J. Wendler, F. Algaba, J.J.M.C.H. de la Rosette, M.P. Laguna Pes. Follow-up after focal therapy in renal masses: an international multidisciplinary Delphi consensus project. World J Urol. 2016 Apr 22.

W. van den Bos, R.R. Jurhill, D.M. de Bruin, C.D. Savci-Heijink, A.W. Postema, P.G. Wagstaff, B.G. Muller, I.M. Varkarakis, A. Skolarikos, P.J. Zondervan, M.P. Laguna Pes, Th.M. de Reijke, J.J.M.C.H. de la Rosette. Histopathological Outcomes after Irreversible Electroporation in Prostate Cancer: Results of an Ablate and Resect Study. J Urol. 2016 Mar 19. pii: S0022-5347(16)03679-X.

P.J. Zondervan, K.P. van Lienden, O.M. van Delden, J.J.M.C.H. de la Rosette, M.P. Laguna Pes. Preoperative Decision Making for Nephron-Sparing Procedure in the Renal Mass: Time for Using Standard Tools? J Endourol. 2016 Jan;30(1):128-34.

M.P. Laguna Pes. Re: Genomic Characterization of Upper Tract Urothelial Carcinoma. JUrol. 2016 Jun;195(6):1719. doi: 10.1016/j.juro.2016.03.029. Epub 2016 Mar 18. PubMed PMID: 27191062.

M.P. Laguna Pes. Re: Prospective Evaluation of(99m)Tc-Sestamibi SPECT/CT fortheDiagnosis of Renal Oncocytomas and Hybrid Oncocytic/Chromophobe Tumors. J Urol. 2016 Jun;195(6):1718-9.

M.P. Laguna Pes. Re: Renal Tumor Biopsy for Small Renal Masses: A Single-Center 13-Year Experience. J Urol. 2016 May;195(5):1378-9.

M.P. Laguna Pes. Re: Partial vs Radical Nephrectomy for T1 Renal Tumours: An Analysis from the British Association of Urological Surgeons Nephrectomy Audit. J Urol. 2016 May;195(5):1377-9.

J. Rioja, E. Morcillo, J.P. Novalbos, M.A. Sánchez, F. Soria, F. Pérez, I. Diaz-Güemes, M.P. Laguna Pes, F.M. Sanchez-Margallo, F.R. Cortadellas. Laparoscopic Partial Nephrectomy with KTP Laser Versus Conventional Laparoscopic Partial Nephrectomy: an Animal Randomized Controlled Trial. Urology. 2016 Apr 21. pii: S0090-4295(16)30093-0.

A. Garde, L. Sörnmo, M.P. Laguna Pes, R. Jané, S. Benito, A. Bayés-Genís, B.F. Giraldo. Assessment of respiratory flow cycle morphology in patients with chronic heart failure. Med Biol Eng Comput. 2016 Apr 23.

O. Barquero-Perez, C. Figuera, R. Goya-Esteban, I. Mora-Jimenez, F.J. Gimeno-Blanes, M.P. Laguna Pes, J.P. Martinez Cortes, E. Gil, L. Sornmo, A. Garcia-Alberola, J.L. Rojo-Alvarez. On the Influence of Heart Rate and Coupling Interval Prematurity on Heart Rate Turbulence. IEEE Trans Biomed Eng. 2016 Apr 15.

G. Gakis, T. Schubert, M. Alemozaffar, J. Bellmunt, B.H. Bochner, S.A. Boorjian, S. Daneshmand, W.C. Huang, T. Kondo, B.R. Konety , M.P. Laguna Pes, S.F. Matin, A.O. Siefker-Radtke, S.F. Shariat, A. Stenzl. Update of the ICUD-SIU consultation on upper tract urothelial carcinoma 2016: treatment of localized high-risk disease. World JUrol. 2016 Apr 4.

P.J. Zondervan, M. Buijs, J.J.M.C.H. de la Rosette, O. van Delden, K. van Lienden, M.P. Laguna Pes. Cryoablation of small kidney tumors. Int J Surg. 2016 Aug 5. pii:S1743-9191(16)30286-2.

M.T. Bus, D.M. de Bruin, D.J. Faber, G.M. Kamphuis, P.J. Zondervan, M.P. Laguna Pes, T.G. van Leeuwen, Th.M. de Reijke, J.J.M.C.H. de la Rosette. Optical Coherence Tomography as a Tool for in Vivo Staging and Grading of Upper Urinary Tract Urothelial Carcinoma: A Study for Diagnostic Accuracy. J Urol. 2016 Jul 27. pii: S0022-5347(16)30924-.

M.J. Scheltema, W. van den Bos, P.G. Wagstaff, A.W. Postema, D.M. de Bruin, M.P. Laguna Pes, J.J.M.C.H. de la Rosette. Irreversible electroporation, a new modality in Focal Therapy for prostate cancer. Arch Esp Urol. 2016 Jul;69(6):337-44.

P.G. Wagstaff, M. Buijs, W. van den Bos, D.M. de Bruin, P.J. Zondervan, J.J.M.C.H. de la Rosette, M.P. Laguna Pes. Irreversible electroporation: state of the art. Onco Targets Ther. 2016 Apr 22;9:2437-46.

W. van den Bos, D.M. de Bruin, A. van Randen, M.R. Engelbrecht, A.W. Postema, B.G. Muller, I.M Varkarakis, A. Skolarikos, C.C. Savci-Heijink, R.R. Jurhill, P.J. Zondervan, M.P. Laguna Pes, H. Wijkstra, Th.M. de Reijke, J.J.M.C.H. de la Rosette. MRI and contrast-enhanced ultrasound imaging for evaluation of focal irreversible electroporation treatment: results from a phase I-II study in patients undergoing IRE followed by radical prostatectomy. Eur Radiol. 2016 Jul;26(7):2252-60.

W. van den Bos, D.M. de Bruin, R.R. Jurhill, C.D. Savci-Heijink, B.G. Muller, I.M. Varkarakis, A. Skolarikos, P.J. Zondervan, M.P. Laguna Pes, H. Wijkstra, Th.M. de Reijke, de la Rosette JJ. The correlation between the electrode configuration and histopathology of irreversible electroporation ablations in prostate cancer patients. World J Urol. 2016 May;34(5):657-64.

M.P. Laguna Pes. Re: The Subclassification of Papillary Renal Cell Carcinoma Does Not Affect Oncological Outcomes after Nephron Sparing Surgery. J Urol. 2016 Sep;196(3):686-7.

M.P. Laguna Pes. Re: Prediction of Complications following Partial Nephrectomy: Implications for Ablative Techniques Candidates. J Urol. 2016 Sep;196(3):685-7.

M.P. Laguna Pes. Re: Prediction of Pulmonary Metastasis in Renal Cell Carcinoma Patients with Indeterminate Pulmonary Nodules. J Urol. 2016 Aug;196(2):350.

M.P. Laguna Pes. Re: Guideline of Guidelines: Follow-up after Nephrectomy for Renal Cell Carcinoma. J Urol. 2016 Aug;196(2):349-50.

M.P. Laguna Pes. Re: Oncologic Surveillance after Surgical Resection for Renal Cell Carcinoma: A Novel Risk-Based Approach. J Urol. 2016 Jul;196(1):58-9.

M.P. Laguna Pes. Re: Comprehensive Characterization of the Perioperative Morbidity of Cytoreductive Nephrectomy. J Urol. 2016 Jul;196(1):57-9.

M.P. Laguna Pes. Re: Characterizing the Impact of Lymph Node Metastases on the Survival Outcome for Metastatic Renal Cell Carcinoma Patients Treated with Targeted Therapies. J Urol. 2016 Apr;195(4P1):900-1.

M.P. Laguna Pes. Re: Genomic Characterization of Upper Tract Urothelial Carcinoma. J Urol. 2016 Jun;195(6):1719.

M.P. Laguna Pes. Re: Prospective Evaluation of(99m)Tc-Sestamibi SPECT/CT fortheDiagnosis of Renal Oncocytomas and Hybrid Oncocytic/Chromophobe Tumors. J Urol. 2016 Jun;195(6):1718-9.

M.P. Laguna Pes. Re: Renal Tumor Biopsy for Small Renal Masses: A Single-Center 13-Year Experience. J Urol. 2016 May;195(5):1378-9.

M.P. Laguna Pes. Re: Partial vs Radical Nephrectomy for T1 Renal Tumours: An Analysis from the British Association of Urological Surgeons Nephrectomy Audit. J Urol. 2016 May;195(5):1377-9.

M.P. Laguna Pes. Re: Health Economic Changes as a Result of Implementation of Targeted Therapy for Metastatic Renal Cell Carcinoma: National Results from DARENCA Study 2. J Urol. 2016 Mar;195(3):608.

M.P. Laguna Pes. Re: Novel Kidney Segmentation System to Describe Tumour Location for Nephron-Sparing Surgery. J Urol. 2016 Jan;195(1):61.

M.P. Laguna Pes. Re: Interobserver Variability of R.E.N.A.L., PADUA, and Centrality Index Nephrometry Score Systems. J Urol. 2016 Jan;195(1):60-1.

M.P. Laguna Pes. Re: Change in Neutrophil-to-Lymphocyte Ratio in Response to Targeted Therapy for Metastatic Renal Cell Carcinoma as a Prognosticator and Biomarker of Efficacy. J Urol. 2016 Dec;196(6):1634-1635.

M.P. Laguna Pes. Re: Nephron-Sparing Surgery across a Nation-Outcomes from the British Association of Urological Surgeons 2012 National Partial Nephrectomy Audit. J Urol. 2016 Dec;196(6):1635.

M.P. Laguna Pes. Re: Five-Year Oncologic Outcomes after Transperitoneal Robotic Partial Nephrectomy for Renal Cell Carcinoma. J Urol. 2016 Nov;196(5):1398.

M.P. Laguna Pes. Re: Natural History of Renal Angiomyolipoma (AML): Most Patients with Large AMLs >4cm can be Offered Active Surveillance as an Initial Management Strategy. J Urol. 2016 Nov;196(5):1397-1398

J.H. Jaunarena, C. Cristallo, M.S. González, F.P. Daels, J.J.M.C.H. De la Rosette, M.P. Laguna Pes. [Management of malignant ureteral obstruction.]. Arch Esp Urol. 2016 Oct;69(8):507-517. Spanish.

M.P. Laguna Pes. Re: Cystic Renal Cell Carcinoma Carries an Excellent Prognosis Regardless of Tumor Size. J Urol. 2016 Oct;196(4):1042-3.

M.P. Laguna Pes. Re: The Subclassification of Papillary Renal Cell Carcinoma Does Not Affect Oncological Outcomes after Nephron Sparing Surgery. J Urol. 2016 Sep;196(3):686-7.

2017:

M.J. Scheltema, K.J. Tay, A.W. Postema, D.M. de Bruin, J. Feller, J.J. Futterer, A.K. George, R.T. Gupta, F. Kahmann, C. Kastner, M.P. Laguna Pes, S. Natarajan, S. Rais-Bahrami, A.R. Rastinehad, T.M. de Reijke, G. Salomon, N. Stone, R. van Velthoven, R. Villani, A. Villers, J. Walz, T.J. Polascik, J.J.M.C.H. de la Rosette. Utilization of multiparametric prostate magnetic resonance imaging in clinical practice and focal therapy: report from a Delphi consensus project. World J Urol.2017 ;35(5):695-701.

G. Gakis, T. Schubert , M. Alemozaffar, J. Bellmunt, B.H. Bochner, S.A. Boorjian, S. Daneshmand, W.C. Huang, T. Kondo, B.R. Konety, M.P. Laguna Pes, S.F. Matin, A.O. Siefker-Radtke, S.F. Shariat, A. Stenzl. Update of the ICUD-SIU consultation on upper tract urothelial carcinoma 2016: treatment of localized high-risk disease. World J Urol. 2017 Mar;35(3):327-335.

M.T. Bus, D.M. de Bruin, G.M. Kamphuis, P.J. Zondervan, M.P. Laguna Pes, Th.M. de Reijke, T.G. van Leeuwen, J.J.M.C.H. de la Rosette. Current position of diagnostics and surgical treatment for upper tract urothelial carcinoma. Minerva Urol Nefrol. 2017 Apr;69(2):159-165.

M. Buijs, K.P. van Lienden, P.G. Wagstaff , M.J. Scheltema, D.M. de Bruin, P.J. Zondervan, O.M. van Delden, T.G. van Leeuwen, J.J.M.C.H. de la Rosette, M.P. Laguna Pes. Irreversible Electroporation for the Ablation of Renal Cell Carcinoma: A Prospective, Human, In Vivo Study Protocol (IDEAL Phase 2b). JMIR Res Protoc. 2017 Feb 16;6(2):e21

J. Baard, J.E. Freund, J.J.M.C.H. de la Rosette, M.P. Laguna Pes. New technologies for upper tract urothelial carcinoma management. Curr Opin Urol. 2017 Mar;27(2):170-175.

M.P. Laguna Pes Re: Clinically Localized Type 1 and 2 Papillary Renal Cell Carcinomas Have Similar Survival Outcomes following Surgery. J Urol. 2017 Jan;197(1):50-51.

M. Smeenge, F. Tranquart, C.K. Mannaerts, Th. M. de Reijke, M.J. van de Vijver, M.P. Laguna Pes, S. Pochon, J.J.M.C.H. de la Rosette, H. Wijkstra. First-in-Human Ultrasound Molecular Imaging With a VEGFR2-Specific Ultrasound Molecular Contrast Agent (BR55) in Prostate Cancer: A Safety and Feasibility Pilot Study. Invest Radiol. 2017 Jul;52(7):419-427.

J. Baard, D.M de Bruin, P.J Zondervan, G. Kamphuis, J.J.M.C.H. de la Rosette, M.P. Laguna Pes. Diagnostic dilemmas in patients with upper tract urothelial carcinoma. Nature Review; Urol.2017Mar;14(3):181-191.

M.P. Laguna Pes. Re: Population-Based Assessment of Cancer-Specific Mortality after

Local Tumour Ablation or Observation for Kidney Cancer: A Competing Risks

Analysis. J Urol. 2017 Feb;197(2):314-315.

D.A. Wollin, A.D. Joyce, M. Gupta, M.Y. Wong, M.P. Laguna Pes, S. Gravas, J. Gutierrez, L. Cormio, K. Wang, G.M. Preminger. Antibiotic use and the prevention and management of infectious complications in stone disease. World J Urol. 2017 Feb 3.

M.P. Laguna Pes. Re: Cost-Effectiveness of Management Options for Small Renal Mass: A Systematic Review. J Urol. 2017 Mar;197(3 Pt 1):602-603.

E.I.M.L. Liem, J. Baard, E.C.C. Cauberg, M.T.J. Bus, D.M. de Bruin, M.P. Laguna Pes, J.J.M.C.H. de la Rosette, Th.M. de Reijke. Fluorescence in situ hybridization as prognostic predictor of tumor recurrence during treatment with Bacillus Calmette-Guérin therapy for intermediate- and high-risk non-muscle-invasive bladder cancer. Med Oncol. 2017 Sep 2;34(10):172.

M.J. Scheltema, A.W. Postema, D.M. de Bruin, M. Buijs, M.R. Engelbrecht, M.P. Laguna Pes, H. Wijkstra, Th.M. de Reijke, J.J.M.C.H. de la Rosette. Irreversible electroporation for the treatment of localized prostate cancer: a summary of imaging findings and treatment feedback. Diagn Interv Radiol. 2017 Sep-Oct;23(5):365-370.

M.P. Laguna Pes. Re: Irreversible Electroporation of Small Renal Masses: Suboptimal Oncologic Efficacy in an Early Series. J Urol. 2017 Sep;198(3):481-482.

M.P. Laguna Pes. Re: Management of Small Renal Masses: American Society of Clinical Oncology Clinical Practice Guideline. J Urol. 2017 Sep;198(3):480-482.

M.P. Laguna Pes. Re: Body Mass Index and Metastatic Renal Cell Carcinoma: Clinical and Biological Correlations. J Urol. 2017 Jul;198(1):36-37.

M.P. Laguna Pes. Re: Robot-Assisted vs Open Adrenalectomy: Evaluation of Cost-Effectiveness and Peri-Operative Outcome. J Urol. 2017 Jun;197(6):1438.

M.P. Laguna Pes. Re: Oncologic Outcomes of Kidney-Sparing Surgery versus Radical Nephroureterectomy for Upper Tract Urothelial Carcinoma: A Systematic Review by the EAU Non-Muscle Invasive Bladder Cancer Guidelines Panel. J Urol. 2017 Jun;197(6):1437-1438.

R.R. Pessoa, R. Autorino, M.P. Laguna Pes, W.R. Molina, D. Gustafson, L. Nogueira, da Silva, P.N. Werahera , F.J. Kim. Laparoscopic Versus Percutaneous Cryoablation of Small Renal Mass: Systematic Review and Cumulative Analysis of Comparative Studies. Clin Genitourin Cancer. 2017;15(5):513-519.

M.P. Laguna. Re: First-Line Sunitinib versus Pazopanib in Metastatic Renal Cell Carcinoma: Results from the International Metastatic Renal Cell Carcinoma. Database Consortium. J Urol. 2017 Mar;197(3 Pt 1):603.

M.P. Laguna. Re: Urinary Collecting System Invasion is Associated with Poor Survival in Patients with Clear-Cell Renal Cell Carcinoma. J Urol. 2017 Nov;198(5):976-978.

M.P. Laguna. Re: Clear Cell Type A and B Molecular Subtypes in Metastatic Clear Cell Renal Cell Carcinoma: Tumor Heterogeneity and Aggressiveness. J Urol. 2017 Nov;198(5):977-978.

M.P. Laguna. Re: Partial Nephrectomy versus Radical Nephrectomy for Clinical T1b and T2 Renal Tumors: A Systematic Review and Meta-Analysis of Comparative Studies. J Urol. 2017 Dec;198(6):1204-1206.

M.P. Laguna. Re: Efficacy of Systemic Chemotherapy plus Radical Nephroureterectomy for Metastatic Upper Tract Urothelial Carcinoma. J Urol. 2017 Dec;198(6):1205-1206.

M.P. Laguna. Re: Mortality, Morbidity and Healthcare Expenditures after Local Tumour Ablation or Partial Nephrectomy for T1A Kidney Cancer. J Urol. 2017 Aug;198(2):252-254

M.P. Laguna. Re: Findings and Impact of Early Imaging after Partial Nephrectomy. J Urol. 2017 Aug;198(2):253-254.

M.P. Laguna. Re: End-Stage Renal Disease after Renal Surgery in Patients with Normal Preoperative Kidney Function: Balancing Surgical Strategy and Individual Disorders at Baseline. J Urol. 2017 May;197(5):1214-1215.

M.P. Laguna. Re: Early Tumour Shrinkage: A Tool for the Detection of Early Clinical Activity in Metastatic Renal Cell Carcinoma. J Urol. 2017 May;197(5):1215.

J.L Boormans, J. Mayor de Castro, L. Marconi, Y. Yuan, M.P. Laguna Pes, C. Bokemeyer, N. Nicolai, F. Algaba, J. Oldenburg, P. Albers. Testicular Tumour Size and Rete Testis Invasion as Prognostic Factors for the Risk of Relapse of Clinical Stage I Seminoma Testis Patients Under Surveillance: a Systematic Review by the Testicular Cancer Guidelines Panel. Eur Urol. 2017 Nov 20. pii: S0302-2838(17)30826-6

2018:

M.P. Laguna. Re: A Phase II Study of Intermittent Sunitinib in Previously Untreated Patients with Metastatic Renal Cell Carcinoma. J Urol. 2018 Jan;199(1):23-25.

M.P. Laguna. Re: Surgical Histopathology for Suspected Oncocytoma on Renal Mass Biopsy: A Systematic Review and Meta-Analysis. J Urol. 2018 Jan;199(1):24-25.

M.P. Laguna. Re: The Impact of Quality Variations on Patients Undergoing Surgery for Renal Cell Carcinoma: A National Cancer Database Study. J Urol. 2018 Feb;199(2):338-339.

M.P. Laguna. Re: When to Perform Preoperative Chest Computed Tomography for Renal Cancer Staging. J Urol. 2018 Feb;199(2):339.

M. Buijs,P.G.K. Wagstaff,D.M. de Bruin, P.J. Zondervan, C.D. Savci-Heijink,O.M. van Delden,T.G. van Leeuwen,R.J.A. van Moorselaar, J.J.M.C.H. de la Rosette, M.P. Laguna Pes. An In-vivo Prospective Study of the Diagnostic Yield and Accuracy of Optical Biopsy Compared with Conventional Renal Mass Biopsy for the Diagnosis of Renal Cell Carcinoma: The Interim Analysis. Eur Urol Focus. 2018 Dec;4(6):978-985

M.T.J. Bus,P. Cernohorsky,D.M. de Bruin,S.L. Meijer,G.J. Streekstra,D.J. Faber, G.M. Kamphuis, P.J. Zondervan,M. van Herk,M.P. Laguna Pes,M.J. Grundeken,M.J. Brandt , T.M. de Reijke, J.J.M.C.H. de la Rosette, T.G. van Leeuwen. Ex-vivo study in nephroureterectomy specimens defining the role of 3-D upper urinary tract visualization using optical coherence tomography and endoluminal ultrasound. J Med Imaging (Bellingham). 2018 Jan;5(1):017001.

A.Basiri, J.J. de la Rosette, S. Tabatabaei, H.H. Woo, M.P. Laguna, H. Shemshaki.Comparison of retropubic, laparoscopic and robotic radical prostatectomy: who is the winner? World J Urol. 2018 Apr;36(4):609-621.

M.P. Laguna. Re: Stereotactic Ablative Body Radiotherapy for Inoperable Primary Kidney Cancer: A Prospective Clinical Trial. J Urol. 2018 Jun;199(6):1393-1394.

M.P. Laguna. Re: Randomized Phase III Trial of Adjuvant Pazopanib versus Placebo after Nephrectomy in Patients with Localized or Locally Advanced Renal Cell Carcinoma. J Urol. 2018 Jun;199(6):1393-1394.

M.P. Laguna. Re: Stereotactic Ablative Body Radiotherapy for Inoperable Primary Kidney Cancer: A Prospective Clinical Trial. J Urol. 2018 Jun;199(6):1393-1394.

M.P. Laguna. Re: Recommendations for the Management of Rare Kidney Cancers. J Urol. 2018 May;199(5):1109.

M.P. Laguna. Re: Intravenous Mannitol versus Placebo during Partial Nephrectomy in Patients with Normal Kidney Function: A Double-Blind, Clinically-Integrated, Randomized Trial. J Urol. 2018 May;199(5):1108-1109.

M.P. Laguna. Re: Defining the Role of Intraoperative Transesophageal Echocardiography during Radical Nephrectomy with Inferior Vena Cava Tumor Thrombectomy for Renal Cell Carcinoma. J Urol. 2018 Apr;199(4):890.

M.P. Laguna. Re: Impact of Diagnostic Ureteroscopy on Intravesical Recurrence in Patients Undergoing Radical Nephroureterectomy for Upper Tract Urothelial Cancer: ASystematic Review and Meta-Analysis. J Urol. 2018 Apr;199(4):889-890.

E.I. Liem, J.E. Freund, J. Baard, D.M. de Bruin,M.P. Laguna Pes,C.D. Savci-Heijink,T.G. van Leeuwen,T.M. de Reijke,J.J. de la Rosette. Confocal Laser Endomicroscopy for the Diagnosis of Urothelial Carcinoma in the Bladder and the Upper Urinary Tract: Protocols for Two Prospective Explorative Studies. JMIR Res Protoc. 2018 Feb7;7(2):e34.

M.P. Laguna. Re: Pathological Heterogeneity in Sporadic Synchronous RenalTumors: Is the Histological Concordance Predictable? J Urol. 2018 Oct;200(4):694-695.

M.P. Laguna. Re: Incidence of T3a Up-Staging and Survival after Partial Nephrectomy: Size-Stratified Rates and Implications for Prognosis. J Urol. 2018 Oct;200(4):695.

L. Sandbergen, S. Guven, M.P. Laguna. Can ablation win against partial nephrectomy and become first line therapy in cT1a renal tumours? Curr Opin Urol. 2019 Jan;29(1):70-77.

M.P. Laguna. Re: A Multigene Signature Based on Cell Cycle Proliferation Improves Prediction of Mortality within 5 Yr of Radical Nephrectomy for Renal Cell Carcinoma. J Urol. 2018 Nov;200(5):941-942.

M.P. Laguna. Re: Patients' Preferences for Adjuvant Sorafenib after Resection of Renal Cell Carcinoma in the SORCE Trial: What Makes it Worthwhile? J Urol. 2018 Sep;200(3): 494-496.

M.P. Laguna. Re: Perioperative Morbidity of Lymph Node Dissection for Renal Cell Carcinoma: A Propensity Score-Based Analysis. J Urol. 2018 Sep;200(3):495-496.

2019:

M.P. Laguna. Re: The Role of Lymph Node Dissection in the Management of Renal Cell Carcinoma: A Systematic Review and Meta-Analysis. J Urol. 2019 Jan;201(1):26-27.

M.P. Laguna. Re: Oncologic Outcomes of Patients with Positive Surgical Margin after Partial Nephrectomy: A 25-Year Single Institution Experience. J Urol. 2019 Jan; 201(1) :27-28

M.P. Laguna. Re: Outcomes of Pathologic Stage T3a Renal Cell Carcinoma Up-Staged from Small Renal Tumor: . J Urol. 2019 Feb;201(2):224-225

M.P. Laguna. Re: Molecular Subtypes of Clear-Cell Renal Cell Carcinoma Are Prognostic for Outcome after Complete Metastasectomy. J Urol. 2019 Apr;201(4):664-665

A. Bex, P. Mulders, M. Jewett, J. Wagstaff, J.V. van Thienen, C.U. Blank, R. van Velthoven, M. del Pilar Laguna, L. Wood, H.H.E. van Melick, M.J.Aarts, J.B. Lattouf, T. Powles, I.J. de Jong, S. Rottey, B. Tombal, S. Marreaud, S. Collette, L. Collette, J. Haanen J. Comparison of Immediate vs Deferred Cytoreductive Nephrectomy in Patients with Synchronous Metastatic Renal Cell Carcinoma Receiving Sunitinib: The SURTIME Randomized Clinical Trial. JAMA Oncol. 2019 Feb 1;5(2):164-170

T. Deng, Y. Chen, B. Liu, M.P. Laguna, J.J.M.C.H. de la Rosette, X. Duan, W. Wu, G. Zeng. systematic review and cumulative analysis of the managements for proximal impacted ureteral stones. World J Urol. 2019 Aug;37(8):1687-1701

M.P. Laguna. Re: The Probability of Aggressive versus Indolent Histology Based on Renal Tumor Size: Implications for Surveillance and Treatment. J Urol. 2019 May;201(5):856

M.P. Laguna. Re: Time Trends in Service Provision and Survival Outcomes for Patients with Renal Cancer Treated by Nephrectomy in England 2000-2010. J Urol. 2019 May;201(5):855

M.P. Laguna. Re: Comparative Effectiveness of Management Options for Patients with Small Renal Masses: . J Urol. 2019 Mar;201(3):439

M.P. Laguna. Re: Active Surveillance for Localized Renal Masses: . J Urol. 2019 Mar;201(3):440.

M.P. Laguna. Re: Adjuvant Vascular Endothelial Growth Factor-Targeted Therapy in Renal Cell Carcinoma: A Systematic Review and Pooled Analysis. J Urol. 2019 Jun;201(6):1050-1051

M.P. Laguna. Re: Below Safety Limits, Every Unit of Glomerular Filtration Rate Counts: Assessing the Relationship between Renal Function and Cancer-Specific Mortality in Renal Cell Carcinoma. J Urol. 2019 Jun;201(6):1049-1050

M.P. Laguna. Re: Diagnostic Needle Biopsies in Renal Masses: Patient and Physician Perspectives. J Urol. 2019 Jul;202(1):28-29

M.P. Laguna. Re: Axitinib versus Placebo as an Adjuvant Treatment of Renal Cell Carcinoma: Results from the Phase III, Randomized ATLAS Trial. J Urol. 2019 Jul;202(1):27-28

M.P. Laguna. Re: Variability in Partial Nephrectomy Outcomes: Does Your Surgeon Matter? J Urol. 2019 Aug;202(2):206-207

M.P. Laguna. Re: Use of Delayed Intervention for Small Renal Masses Initially Managed with Active Surveillance. J Urol. 2019 Aug;202(2):207

M.P. Laguna. Re: Clonal Relatedness and Mutational Differences between Upper Tract and Bladder Urothelial Carcinoma. J Urol. 2019 Sep;202(3):456-457

M.P. Laguna. Re: Intensive Imaging-Based Follow-up of Surgically Treated Localised Renal Cell Carcinoma Does Not Improve Post-Recurrence Survival: Results from a European Multicentre Database (RECUR). J Urol. 2019 Sep;202(3):455-456

M.J. Scheltema, T.J. O'Brien, W. van den Bos, D.M. de Bruin, R.V. Davalos, C.W.M. van den Geld, M.P. Laguna, R.E. Neal 2nd, I.M. Varkarakis, A. Skolarikos, P.D. Stricker, T.M. de Reijke, C.B. Arena, J. de la Rosette. Numerical simulation modeling of the irreversible electroporation treatment zone for focal therapy of prostate cancer, correlation with whole-mount pathology and T2-weighted MRI sequences. Ther Adv Urol. 2019 Jun 7;11:1756287219852305.

M.P. Laguna. Re: Comparison of RENAL, PADUA, CSA, and PAVP Nephrometry Scores in Predicting Functional Outcomes after Partial Nephrectomy. J Urol. 2019 Oct;202(4):657-658

M.P. Laguna. Re: The Prognostic Value of the Site of Invasion in T3aN0M0 Clear Cell Renal Cell Carcinoma. J Urol. 2019 Nov;202(5):863-864

M.P. Laguna. Re: Development and External Validation of a Nomogram Predicting Prognosis of Upper Tract Urothelial Carcinoma after Radical Nephroureterectomy. J Urol. 2019 Dec;202(6):1093-1094

M.P. Laguna. Re: Nephrometry Score Correlated with Tumor Proliferative Activity in T1 Clear Cell Renal Cell Carcinoma. J Urol. 2019 Dec;202(6):1094

2020:

M. Shahait, S. Jackman, J. Landman, E. Lechevallier, I. Billiet, L. Fossion, Y. Aslan, M.P. Laguna. Utilization and Operative Influence of Renal Mass Biopsy in the Small Renal Mass: Analysis from the Clinical Research Office of the Endourological Society Small Renal Mass registry. J Endourol. 2020 Jan;34(1):99-106

L. Sandbergen, A.S. Spriensma, J.J. de la Rosette, M.P. Laguna. Health-related quality of life in localized renal masses: A matter of sparing nephrons or minimizing the incision? Urol Oncol. 2020 Feb;38(2):43.e1-43.e11

J. Baard, M. Celebi, J. de la Rosette, A. Alcaraz. S. Shariat, L. Cormio, V, Cavadas, M.P. Laguna. Evaluation of Patterns of Presentation, Practice, and Outcomes of Upper Tract Urothelial Cancer: Protocol for an Observational, International, Multicenter, Cohort Study by the Clinical Research Office of the Endourology Society. JMIR Res Protoc. 2020 Jan 24;9(1):e15363

M.P. Laguna. Re: Evaluation of Axitinib to Downstage cT2a Renal Tumours and Allow Partial Nephrectomy: A Phase II Study. J Urol. 2020 Jan;203(1):28-29

M.P. Laguna. Re: Oncologic Outcomes following Partial Nephrectomy and Percutaneous Ablation for cT1 Renal Masses. J Urol. 2020 Jan;203(1):27-28

M.P. Laguna. Re: Are There Differences between de Novo and Secondary Upper Tract Urothelial Carcinoma Tumours? J Urol. 2020 Feb;203(2):249-250

M.P. Laguna. Re: Postoperative Complications Increase the Risk of Long-Term Chronic Kidney Disease after Nephron-Sparing Surgery in Patients with Renal Cancer and Normal Preoperative Renal Function. J Urol. 2020 Feb;203(2):248-249

M.P. Laguna. Re: The Simplified PADUA REnal (SPARE) Nephrometry System: A Novel Classification of Parenchymal Renal Tumours Suitable for Partial Nephrectomy. J Urol. 2020 Mar;203(3):459-460

M.P. Laguna. Re: Clinicopathological and Survival Analysis of Clinically Advanced Papillary and Chromophobe Renal Cell Carcinoma. J Urol. 2020 Mar;203(3):460-461.J Urol. 2019 Dec 10:101097JU000000000000067501. doi: 10.1097/JU.0000000000000675.01. [Epub ahead of print]

M.J. Ribal, P. Cornford, A. Briganti, T. Knoll, S. Gravas,M. Babjuk, C. Harding, A. Breda, A. Bex; GORRG Group, J.J. Rassweiler, A.S. Gözen, G. Pini, E. Liatsikos, G. Giannarini, A. Mottrie, R. Subramaniam, N. Sofikitis, B.M.C. Rocco, L.P. Xie, J.A. Witjes, N. Mottet , B. Ljungberg, M. Rouprêt, M.P.Laguna, A. Salonia, G. Bonkat, B.F.M. Blok, C. Türk, C. Radmayr, N.D. Kitrey, D.S. Engeler, N. Lumen, O.W. Hakenberg, N. Watkin, R. Hamid, J. Olsburgh, J. Darraugh, R. Shepherd, E.J. Smith, C.R. Chapple, A. Stenzl, H. Van Poppel, M. Wirth, J. Sønksen, J. N'Dow; EAU Section Offices and the EAU Guidelines Panels. European Association of Urology Guidelines Office Rapid Reaction Group: An Organisation-wide Collaborative Effort to Adapt the European Association of Urology Guidelines Recommendations to the Coronavirus Disease 2019 Era. Eur Urol. 2020 Jul;78(1):21-28

J. Mayor, M. Álvarez-Maestro, JÁ Arranz,M.P. Laguna. De-escalation: Testicular cancer. Arch Esp Urol. 2020 Jun;73(5):390-394.

Y. Kordan, A.E. Canda, E. Köseoğlu, D. Balbay, M.P.Laguna, J.J. de la Rosette. Robotic-Assisted Simple Prostatectomy: A Systematic Review. Clin Med. 2020 Jun 9;9(6):1798.

M.P. Laguna Re: Evolving Trends for Selected Treatments of T1a Renal Cell Carcinoma. J Urol. 2020 May;203(5):877

M.P. Laguna Re: Effect of Renal Mass Biopsy on Subsequent Nephrectomy Outcomes: A Population-Based Assessment. J Urol. 2020 Jun;203(6):1059-1060.

M.P. Laguna Urological Oncology: Adrenal, Renal, Ureteral and Retroperitoneal Tumors. J Urol. 2021 Jan;205(1):301-302

M.P. Laguna Re: Renal Mass Biopsy is Associated with Reduction in Surgery for Early-Stage Kidney Cancer.J Urol. 2020 May;203(5):878

M.P. Laguna Re: Impact of Hospital Nephrectomy Volume on Intermediate- to Long-Term Survival in Renal Cell Carcinoma. J Urol. 2020 Nov;204(5):1092-1093.

M.P. Laguna Re: Impact of Acute Kidney Injury and its Duration on Long-Term Renal Function after Partial Nephrectomy. J Urol. 2020 Apr;203(4):658-659

M.P. Laguna Re: Three-Dimensional Virtual Imaging of Renal Tumours: A New Tool to Improve the Accuracy of Nephrometry Scores.J Urol. 2020 Jul;204(1):182.

M.P. Laguna Re: Psychological Distress Associated with Active Surveillance in Patients Younger Than 70 with a Small Renal Mass. J Urol. 2020 Dec;204(6):1377

M.P. Laguna Re: Next-Generation RNA Sequencing-Based Biomarker Characterization of Chromophobe Renal Cell Carcinoma and Related Oncocytic Neoplasms. J Urol. 2020 Dec;204(6):1376

M.P. Laguna Re: Comparing Outcomes for Patients with Clinical T1b Renal Cell Carcinoma Treated with either Percutaneous Microwave Ablation or Surgery. J Urol. 2020 Jun;203(6):1058-1059.

M.P. Laguna Re: Development and Validation of a Robust Multigene Signature as an Aid to Predict Early Relapse in Stage I-III Clear Cell and Papillary Renal Cell Cancer. J Urol. 2020 Oct;204(4):875.

M.P. Laguna Re: Effect of Obesity and Overweight Status on Complications and Survival after Minimally Invasive Kidney Surgery in Patients with Clinical T2-4 Renal Masses. J Urol. 2020 Aug;204(2):383-384.

M.P. Laguna Re: Prediction of Significant Estimated Glomerular Filtration Rate Decline after Renal Unit Removal to Aid in the Clinical Choice between Radical and Partial Nephrectomy in Patients with a Renal Mass and Normal Renal Function. J Urol. 2020 Jul;204(1):181

M.P. Laguna Re: Long-Term Risk of Recurrence in Surgically Treated Renal Cell Carcinoma: A Post Hoc Analysis of the Eastern Cooperative Oncology Group-American College of Radiology Imaging Network E2805 Trial Cohort. J Urol. 2020 Sep;204(3):614-615.

M. Amaresh, P. Hegde, A. Chawla, J.J.M.C.H. de la Rosette, M.P.Laguna, A. Kriplani. Safety and efficacy of superior calyceal access versus inferior calyceal access for pelvic and/or lower calyceal renal calculi- a prospective observational comparative study. World J Urol. 2020 Aug 31 doi: 10.1007/s00345-020-03409-3. Online ahead of print.

M.P. Laguna Re: Transplanting Kidneys from Donors with Small Renal Masses-A Strategy to Expand the Donor Pool. J Urol. 2020 Aug;204(2):382

M.P. Laguna Re: Chest Computed Tomography for Staging Renal Tumours: Validation and Simplification of a Risk Prediction Model from a Large Contemporary Retrospective Cohort. J Urol. 2020 Nov;204(5):1093-1094

J. de la Rosette, P. Laguna, M. Álvarez-Maestro, M. Eto, C.A. Mochtar, S. Albayrak, A. Mendoza-Valdes, T.A. Ong, S. Khadgi, A. Al-Terki, D. Bolton, R. Gomez, L. Klotz, S. Kulkarni, S. Tanguay, S. Gravas; Société Internationale d’Urologie Board of Directors. Cross-continental comparison of safety and protection measures amongst urologists during COVID-19. Int J Urol. 2020 Nov;27(11):981-989.

S. Morselli, A. Liaci, R. Nicoletti, A. Pecoraro, L. Gemma, P. Polverino, C. Zaccaro, A. Sebastianelli, S Serni, P. Laguna,J.J.M.C.H. de La Rosette, S. Gravas, M. Gacci. The use of a novel smartphone app for monitoring male luts treatment during the COVID-19 outbreak. Prostate Cancer Prostatic Dis. 2020 Dec;23(4):724-726.

R.S. Guddeti, P. Hegde, A. Chawla,J.J.M.C.H. de la Rosette, M.P. Laguna Pes, A. Kapadia. Super-mini percutaneous nephrolithotomy (PCNL) vs standard PCNL for the management of renal calculi of <2cm: a randomised controlled study. BJU Int. 2020 Aug;126(2):273-279.

S. Yıldırım, D. Shoskes, S. Kulkarni, P.Laguna. Urinary microbiome in uncomplicated and interstitial cystitis: is there any similarity?.World J Urol. 2020 Nov;38(11):2721-2731

Tous Les Résultats

Prof.Dr. Maria Del Pilar Laguna PES

Lieu de naissance

Langues étrangères

Expérience

Formation

Publications

MEDİPOL MEGA